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ABSTRACT
Calponins (CaPs) are actin-binding proteins that stabilize actin filaments. Mammals 
express three genetic isoforms in a tissue-specific manner. CaPs share an N-terminal 
calponin-homology (CH) domain followed by short tandem sequence repeats termed 
calponin-like (CLIK23) repeats. The extreme C-termini of CaPs contain isoform- 
specific tail sequences. Basic calponin (hlCaP) was the first isoform to be discovered 
22 years ago in an attempt to identify troponin-like proteins in smooth muscle. HlCaP 
is mainly expressed in smooth muscle cells and was shown to regulate contraction by 
inhibiting actin-activated myosin ATPase activity. Several mechanisms have been 
proposed for the regulation of the actin-binding activity of hlCaP. One mechanism is 
based on phosphorylation. HlCaP phosphorylation inhibits its interaction with actin 
filaments and releases the block on the myosin ATPase activity in vitro. However, in 
vivo it has not been unequivocally demonstrated whether hlCaP is phosphorylated or 
not. The binding of extracellular regulated kinase (ERK) but not phosphorylation was 
proposed as another regulatory mechanism, but the physiological relevance of this 
interaction remains elusive. Therefore, the scope of this thesis was to reveal the 
mechanisms that regulate the actin-binding activity of hlCaP. First, the contribution 
of the major hlCaP phosphorylated sites to its actin-binding activity was re-evaluated. 
A mutant hlCaP mimicking its phosphorylated state behaved, however, similar to 
wild-type hlCaP. Thus, another regulatory mechanism was explored. It has 
previously been shown that the C-terminal tails regulate the actin-binding activity of 
all three CaP isoforms. Also, electron microscopy images of purified hlCaP show a 
flexible molecule that can adopt both an extended and a more compact conformation, 
and it was recently shown that the CH domain does not mediate the actin binding- 
activity of hlCaP. In light of the flexibility of hlCaP and the demonstrated regulatory
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role of the C-terminal tail, a possible regulatory mechanism could thus involve an 
intramolecular interaction between different domains. Therefore, the contribution of 
the C-terminal tail and the CH domain of hlCaP to its actin-binding activity was 
investigated in cells. The results suggest that the hlCaP CH domain blocks the 
inhibitory effects of its tail, which could be mediated by a CH domain-tail interaction. 
Therefore, the interaction between the CH domain and the tail was modelled and the 
plausibility of their interaction was predicted in silico. Furthermore, the interaction 
between these two domains was demonstrated in vitro using recombinant proteins.
The proximity between the CH domain and the tail was also analyzed using FRET 
imaging in live cells, and the region encompassing helix A and loop 1 of the CH 
domain was determined to be the binding region for the tail. These results suggest that 
the binding of hlCaP to actin filaments is modulated by an interaction between the 
hlCaP N-terminal CH domain and its C-terminal tail.
One aspect of the potential in-vivo functions of hlCaP that has been neglected 
so far relates to its actin-binding activity during cell division. It has previously been 
reported that overexpression of CaP reduces cell proliferation and increases the 
number of bi-nucleated cells. This suggests that CaPs have a role during mitosis.
Thus, the localization of CaPs during cell division was investigated and the data 
presented in this study demonstrate the specific accumulation of CaP at the ingression 
furrow and the contractile ring, suggesting a role in cytokinesis. Furthermore, 
overexpression of hlCaP mutants led to cell division defects. In summary, this study 
has revealed a novel regulatory mechanism that controls the actin-binding activity of 
hlCaP, which is mediated by the intramolecular interaction of its CH domain and its 
C-terminal tail.
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CHAPTER 1: INTRODUCTION
1.1 Cytoskeleton
The idea of the cytoskeleton dates back to the beginning of the 20th century. In 
1929, Parker suggested the presence of fibrils that might have a supportive role for the 
cytoplasm (Parker, 1929). A similar idea was already proposed in 1916 from the 
observation of egg cells from the gastropod Crepidula plana recovering their original 
shape after being exposed to a stress (Conklin, 1916). However, it was not until 1940, 
with the advance of electron microscopy and protein biochemistry that a clearer 
picture of the components of the cytoskeleton started to emerge. Electron microscopy 
together with the advance of thin-sectioning technology led to the distinction of two 
types of cytoskeletal filaments, the actin filaments (F-actin), also called 
microfilaments, and microtubules (Hanson and Huxley, 1953; Huxley, 1953; Pease, 
1963; Phillips, 1966). While actin filaments have been discovered for the first time in 
studies of striated muscle, microtubules were discovered as the main structures of cilia 
and flagella. The dawn of monoclonal antibody production (circa 1970) allowed the 
creation of highly specific reagents that significantly advanced the ability to identify 
and detect the intracellular distribution of actin and microtubule filaments (Fuller et 
al., 1975; Lazarides and Weber, 1974; Weber et al., 1975). Indeed, this biotechnology 
led to the discovery of a third type of cytoskeletal filament termed intermediate 
filaments (Bignami et al., 1972; Fuchs and Green, 1978; Lazarides and Hubbard, 
1976).
Today, it is well established that these filaments can be distinguished on the 
basis of their diameter, type of protein subunit, arrangement of the subunits, and their 
cellular functions. The cytoskeleton is involved in diverse functions, such as cell
5
migration, cell shape regulation, cell division, transport of organelles and molecules, 
cell-cell and cell-substrate attachment, anchorage of metabolic pathways to a specific 
location within the cytoplasm, and integration of molecular signalling processes.
Microtubules are present in all eukaryotes. They are the structural components 
of cilia and flagella in eukaryotic cells and they contribute to the transport of vesicles, 
to cell shape, to the positioning of the nucleus and organelles, and to chromosome 
segregation during cell division. Microtubules are made of repeating globular a/(3- 
tubulin heterodimers that are arranged in a cylindrical array of 24 nm diameter, a- and 
p- tubulin are 50% identical at the amino-acid level, and each subunit has a molecular 
weight of ~50-kDa (Burns, 1991). Microtubules are highly dynamic, and polymerize 
or depolymerize according to the needs of the cell. The dynamics of microtubules is 
regulated by binding and hydrolysis of guanosine triphosphate (GTP) by P-tubulin 
subunits (Desai and Mitchison, 1997), and the interactions with a large number of 
microtubule-associated proteins. The two ends of the microtubule have different rates 
of assembly due to the head to tail association of the cx/p-heterodimer (Amos and 
Klug, 1974), designated as plus and minus for the fast and slow assembly ends, 
respectively. Structurally, a microtubule is formed by an arrangement of 13 
protofilaments of a- and p-tubulin associated laterally with the P-tubulin pointing 
towards the plus end and the a-tubulin towards the minus end of the microtubule. 
There is a cytosolic structure that plays a crucial role in the dynamic microtubules 
known as the microtubule-organizing center (MTOC), where microtubules are 
attached at their minus ends and that is involved in the assembly and orientation of 
microtubules. A third tubulin isoform, y-tubulin, localizes at MTOCs and is essential 
for microtubule nucleation, helping the formation of ring structures that serve as 
templates for microtubule growth (Moritz et al., 1995). During cell division
microtubules localize at the mitotic spindle, thus termed spindle microtubules, and 
organize and distribute chromosomes to the daughter cells (Karsenti and Vernos, 
2001).
Intermediate filaments are made of fibrous proteins that usually adopt a rope­
like structure by forming coiled coils, and filament polymerization is independent of 
nucleotide hydrolysis. There are many different proteins that can form intermediate 
filaments, which are encoded for by 65 human genes (Oshima, 2007). The subunits of 
the filaments are grouped into five classes: Class 1 and 2 include keratins, class 3 
includes vimentin and desmin, class 4 includes neurofllaments (NFs), and class 5 
includes nuclear lamins. The expression of these proteins is tissue specific. The 
intermediate filaments of epithelia are made of keratin subunits while muscle and 
mesenchymal cell intermediate filaments are made of desmin and vimentin, 
respectively. On the other hand, NFs are expressed in neurons, and lamins are 
ubiquitously expressed and localize inside the nuclear envelope of the cells. Despite 
the structural similarity of different types of intermediate filaments, the amino-acid 
sequences of the protein subunits are not conserved. However, structural analysis of 
the protein subunits has allowed some generalizations regarding their functional 
domains. A conserved central a-helical rod domain is flanked by non-a-helical N- 
terminal (termed the head) and C-terminal (termed the tail) end domains (Goldman et 
al., 2008). The central rod enables the formation of a coiled-coil structure, whilst the 
head and tail domains are variable in size and sequence and contribute to the 
functional diversity of the intermediate filaments (Steinert and Parry, 1985; Weber 
and Geisler, 1982). The head and tail domains are important sites of regulation and 
interaction with other cellular elements. Three modes of intermediate filament 
polymerization have been described depending on the type of subunit: 1) lamins form
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dimers that associate into head-to-tail protofilaments, which further associate laterally 
(Stuurman et al., 1998); 2) the assembly of vimentin-type filaments starts from the 
association of two antiparallel vimentin dimers that form a tetramer, followed by 
lateral annealing and longitudinal elongation, which yield long and thick filaments 
(Herrmann et al., 1996); and 3) keratin intermediate filaments assemble from 
heterodimers of acidic and basic keratins, which then associate into tetramers by 
lateral association and longitudinal elongation (Herrmann et al., 2002).
Intermediate filaments do not contribute to cell motility and no motor proteins 
are known to be associated with them; thus, it is thought that intermediate filaments 
play a mainly structural role within the cell. Recently, various skin fragility and 
muscle disorders, such as Emery-Dreifuss muscular dystrophy, have been shown to be 
associated with point mutations in genes encoding for intermediate filament proteins 
(Bonne et al., 1999; Fatkin et al., 1999).
Actin filaments, or microfilaments, are polymers of globular actin (G-actin) 
(Mommaerts, 1952) that together with a large number of actin binding and associated 
proteins constitute the actin cytoskeleton. The actin cytoskeleton is dynamic, able to 
adapt to demands of the cell and is involved in a variety of cellular functions such as 
locomotion, cell shape regulation, cell division, intracellular trafficking, cell 
contraction and relaxation, endocytosis, and secretion (Bretscher, 1993; Gottlieb et al., 
1993; Juliano and Haskill, 1993; Luna and Hitt, 1992; Salmon, 1989). In addition, the 
actin cytoskeleton also controls cell-cell and cell-substrate adhesion. Each actin 
molecule can bind adenosine triphosphate (ATP), which is hydrolyzed to adenosine 
diphosphate (ADP) after incorporation of an actin molecule into the polymer.
Although energy is not required for actin polymerization in vitro, ATP-bound actin 
polymerizes faster than ADP-bound actin (Engel et al., 1977). All subunits in an actin
filament point towards the same end of the filament; thus, an actin filament exhibits 
polarity.
1.2 Actin
The assembly of G-actin to form F-actin is essential for the actin cytoskeleton 
to carry out the variety of its cellular functions. Actin is a 43-kDa protein and is 
present in all eukaryotic cells. There are six genetic isoforms in higher mammals 
(Vandekerckhove and Weber, 1978): two smooth muscle actins (a-smooth muscle 
actin and y-smooth muscle actin), two striated muscle actins (cx-skeletal actin and a- 
cardiac actin) and two cytoplasmic actins (|3-cytoplasmic actin and y-cytoplasmic 
actin). These actins exhibit a high degree of amino-acid sequence similarity (e.g. 
skeletal muscle a-actins of human, mouse, rat, rabbit and chicken are identical 
(Hennessey et al., 1993). Most species have several actin genes, like the worm 
Caenorhabdites elegans that has four distinct actin genes (Krause et al., 1989) and 
plants that have between five and eight different actins (McLean et al., 1990). On the 
other hand, lower eukaryotes, like the yeast Saccharomyces cerevisiae carry only a 
single actin gene (Gallwitz and Sures, 1980). The six human actin genes are ACTA1 
(a-skeletal actin), ACTA2 (a-smooth muscle actin), ACTB (p-cytoplasmic actin), 
ACTC (a-cardiac actin), ACTG1 (y- cytoplasmic actin) and ACTG2 (y-smooth 
muscle actin). Mutations in human actin genes have been detected only during the last 
10 years due to their low frequencies in the human population and to their severe 
effects. Mutations in the ACTC gene have been found in several cardiomyopathies 
(Mogensen et al., 1999; Olson et al., 1998). Mutations in the ACTA1 and ACTG1 
genes have been found in congenital myopathies and deafness, respectively (Nowak et 
al., 1999; Zhu et al., 2003). Interestingly, the majority of actin-related diseases are
dominant due to the fact that most of the mutations produce missense mutations that 
lead to a defective actin monomer, which is unable to polymerize correctly 
(Hennessey et al., 1993). Prokaryotic cells have actin homologues, although they 
share less than 15% sequence homology (Bork et al., 1992). The bacterial actins are 
termed FtsA, MreB and StbA (or ParM) and their crystal structures show conservation 
of specific functional motifs that are related to eukaryotic actin, and which are 
involved in polymerization (Roeben et al., 2006; van den Ent and Lowe, 2000). MreB 
assembles into filaments that are similar to eukaryotic actin (Jones et al., 2001; van 
den Ent et al., 2001). The subtle differences in the amino-acid sequences of eukaryotic 
actin isoforms confer functional diversity and allow actin isoforms to segregate into 
different structures within cells (Denning et al., 1988; DeNofrio et al., 1989; Otey et 
al., 1988; Rubenstein et al., 1982).
Under conditions used to grow protein crystals actin monomers have the 
propensity to spontaneously self-assemble into filaments, hence the first actin 
monomer crystal structure was determined in the presence of the actin-monomer 
binding protein DNAse I, which blocks actin polymerization (Kabsch et al., 1990; 
Mannherz et al., 1977). The crystal structure of actin in the absence of an actin- 
binding protein has been reported later (Otterbein et al., 2001) (Fig. 1). G-actin 
displays four prominent domains numbered 1-4. Domains 1 and 2 are separated from 
3 and 4 by a cleft that is occupied by an ATP or ADP complexed with a Mg2+ ion 
(Kinosian et al., 1993). The end of the filament at which the ATP/ADP-binding cleft 
of the actin subunit is exposed is designated the minus or pointed end (domains 2 and 
4) while the opposite side is the plus or barbed end (domains 1 and 3).
1 0
Subdomain 4 Subdomain 2
ATP
ADP
Subdomain 3
Subdomain 1
Figure 1. Ribbon representation of the crystal structure of the actin monomer. The 
four domains are represented in different colors. ADP or ATP is bound at the centre 
of the molecule, inside the cleft (modified from Otterbein et al., 2001; Kabsch et al., 
1990).
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1.3 Assembly and regulation of actin filaments
Unlike the actin monomer, no atomic structure has been solved for F-actin, 
although models have been proposed (Holmes et al., 1990) and low level structural 
data have been presented (Oda et al., 2001; Popp et al., 1987) (Fig.2). Each monomer 
is found surrounded by four others in a filament. Actin filaments are constantly 
polymerizing and depolymerizing inside the cell. Association and dissociation of actin 
monomers from the filament can occur at both ends, but association predominantly 
occurs at the barbed end and dissociation from the pointed end (Wegner, 1976).
In vitro under low ionic strength conditions, e.g., 0.2 mM Ca2+ or 0.05 mM 
Mg2+, actin is monomeric, and elevating the ionic strength to physiological conditions, 
e.g., 2 mM MgCl2 or 100 mM KC1, causes monomeric G-actin to polymerize into 
synthetic F-actin (Kasai et al., 1962b). In-vitro polymerization of actin occurs in three 
steps (Kasai et al., 1962a; Kasai et al., 1962b). The first is the nucleation phase, which 
is characterized by an energetically unfavourable process of aggregating actin 
monomers to form a stable trimer, which can support the addition of further actin 
monomers for the formation of actin filaments. The elongation phase is the second 
step and filaments are rapidly formed in this phase. At the third step, a steady-state 
phase is reached, and there is an equilibrium between filaments and monomers. 
Exchange of actin monomers continues at the ends of the filament, but the total mass 
remains the same. The flux of actin subunits between the pointed end and the barbed 
end is known as treadmilling (Wegner, 1976). The rate of treadmilling or the 
assembly/disassembly process of actin filaments is regulated by actin-binding proteins 
(ABPs). Some of the functions of ABPs include severing or capping of actin 
filaments, nucleating actin monomers for polymerization, and filament cross-linking
1 2
F-actin G-actin
barbed end
Subdomain 3
Figure 2. Model of the F-actin structure. The F-actin model comprises five actin 
monomers (blue, red, green, white and yellow). Each actin monomer is surrounded by 
four others in a filament (green monomer). Association of monomers occurs at the 
barbed end, and dissociation from the pointed end. During actin filament maturation, 
ATP-G-actin is converted to ADP-G-actin.
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and stabilization. Other ABPs can bind and sequester actin monomers. Several toxins 
can promote depolymerization or stabilization of actin filaments. Cytochalasin is a 
fungal alkaloid that binds to the plus ends of the actin filaments, thus inhibiting the 
association and dissociation of actin subunits at that end, and resulting in the 
depolymerization of the actin filament (Cooper, 1987). Latrunculin is another toxin 
found in the sponge Latrunculia magnified (Spector et al., 1983) and it binds and 
sequesters actin monomers and prevents their addition to actin filaments, thus also 
resulting in the depolymerization of the filaments (Coue et al., 1987). Phalloidin is a 
bicyclic heptapeptide purified from the poisonous mushroom Amanita (Lengsfeld et 
al., 1974). In contrast to latrunculin and cytochalasin, phalloidin binds to the actin 
filament, thus stabilizing it and protecting it from depolymerization. These three 
toxins are widely used for actin cytoskeleton studies due to their specificities.
The functional diversity of ABPs dictates (or defines) the multiple and distinct 
roles of actin filaments in the cell. Filaments at the leading edge of a migrating cell 
(lamellipodium) are dynamic and compositionally different from actin filaments that 
are responsible for contraction in skeletal, cardiac and smooth muscle cells and also 
from the actin filaments of the microvilli that are found at the apical surface in 
epithelial cells of the intestine.
1.3.1 Actin filaments in motile cells
The actin cytoskeleton plays an important role in eukaryotic cell motility, and 
many processes depend on locomotion including embryonic development, 
chemotactic movement of immune cells, and fibroblast migration. Movement is 
characterized by cytoplasmic membrane extensions termed pseudopods and 
depending on their morphology, are called lamellipodia (observed at the leading edge
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of many migrating cells; Fig. 3A), filopodia (spike-like extensions) or ruffles (similar 
to lamellipodia but with more membrane irregularities; Fig. 3B). Behind the 
lamellipodia lie bundles of actin filaments termed stress fibres, which are held 
together by actin-crosslinking proteins (e.g. a-actinin and filamin). Following the 
classification of Small, stress fibres can be divided into three classes on the basis of 
their subcellular location (Small et al., 1998): 1) ventral stress fibres, 2) dorsal stress 
fibres and 3) transverse arcs (Fig. 3C and D). Ventral stress fibres are positioned 
along the base of the cell, attached at both ends to focal adhesions, which are 
structures that connect the actin cytoskeleton with the extracellular matrix. Dorsal 
stress fibres are attached to focal adhesions from one end at the base of the cell and 
ascend towards the dorsal surface (Heath and Dunn, 1978). Transverse arcs are actin 
bundles that form beneath the dorsal surface and behind the lamellipodia (Heath, 
1983).
Each type of stress fibre is assembled by a different mechanism and associated 
with different ABPs. Dorsal stress fibres elongate from focal adhesions. Ventral stress 
fibres are formed by end-to-end joining of two dorsal stress fibres rendering a 
structure that is anchored at both ends by focal adhesions (Fig. 4). In contrast, 
transverse arcs form by joining small actin bundles and they are not attached to focal 
adhesions (Hotulainen and Lappalainen, 2006). An important component of stress 
fibres is the motor protein myosin, which is found associated with actin and forms an 
actomyosin complex. Myosin is essential for stress fibre contraction, although polarity 
alternation of the actin filaments within a stress fibre is also important (Cramer et al., 
1997). Polarity alternation of actin filaments allows their movement in opposite 
directions by myosin, which results in contraction. Dorsal stress fibres show uniform 
polarity, thus it is thought that they do not contract. On the other hand, ventral and
15
arcs
dorsal
ventra
Figure 3. A7r5 smooth muscle cells stained with phalloidin. (A) Cell showing a 
polarized lamellipodia and long ventral stress fibres. (B) Ruffles are seen at the 
periphery of the cell. (C) and (D) shows the three classes of filaments following the 
classification of Small; ventral stress fibres (red), dorsal stress fibres (yellow) and 
transverse arcs (green). [FI] actin filament, [LM] lamellipodia, [RF] membrane 
ruffles.
formation of ventral stress fibres
step 1 step 2 step 3
T ▼
A
focal adhesion A G-actin   membrane actin crosslinker myosin
Figure 4. Formation of a ventral stress fibre. Actin filaments polymerize from focal 
adhesions towards the interior of the cell (step 1). Actin crosslinking proteins (green) 
crosslink filaments and can stabilize them in an antiparallel fashion (step 2). The 
antiparallel organization of actin filaments is exploited by myosin (blue), to move the 
filaments and generate a contractile force that is transmitted to the actin network (step
3).
T T 
▼ T 
T ▼
1 1
W *!1tit
A 
A
Lim * t
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transversal arc stress fibres show polarity alternation since they are made by end-to- 
end joining of shorter filaments.
1.3.2 Regulation of actin filaments at the leading edge of motile cells
The extension of lamellipodia in migrating cells is an actin-based process that 
is highly polarized, and specific molecular components are required for the dynamic 
assembly of this cytoskeletal network. Interestingly, actin fibres of the lamellipodia 
arrange in uniform parallel arrays similar to dorsal stress fibres. Protrusion at the 
leading edge is regulated by the actin-related protein (Arp) 2/3 complex. Arp2/3 is a 
multimeric protein complex that regulates the actin cytoskeleton in many different 
ways (Goley and Welch, 2006). The Arp2/3 complex binds to actin filaments, creates 
70° branches and acts as a crosslinker (Fig. 5). The Arp2/3 complex consists of seven 
polypeptides termed Arp2 of 45-kDa, Arp3 of 47-kDa, actin-related protein complex 
(Arpc) 1 of 41-kDa, Arpc2 of 34-kDa, Arpc3 of 21-kDa, Arpc4 of 20-kDa and Arpc5 
of 16-kDa (Goley and Welch, 2006). Arp2/3 promotes actin filament formation by the 
generation of templates that nucleate actin polymerization (Welch et al., 1997) and 
initiates actin filament branches by binding to the sides of existing filaments 
(Fujiwara et al., 2002; Mullins et al., 1998; Yolkmann et al., 2001). The result of this 
process is an active polymerization process of actin filaments that pushes the 
membrane forward.
Three different ways used by cells to trigger actin polymerization have been 
proposed (Higgs and Pollard, 1999): 1) de novo nucleation of filaments from 
monomeric actin; 2) severing of existing filaments to create uncapped barbed ends 
and; 3) uncapping of existing barbed ends. Until the discovery of the Arp2/3 complex, 
no protein was known to have an actin-nucleating activity. The nucleation activity of
17
A RP?/} Complex
6
Figure 5. Upper panel: Multiple branching of actin filaments in lamellipodia. electron 
micrograph of lamellipodia of Xenopus keratocytes (a-g) showing an overview of the 
leading edge (a) and enlargements of the boxed regions (b-g). Many examples of 
filaments with multiple branches (cyan) can be visualized in lamellipodia despite the 
high overall density of the actin network (from Svitkina and Borisy, 1999).
Lower panel: Scheme of nucleation of actin polymerization by the Arp2/3 complex 
based on Goley and Welch, 2006. The Arp2/3 complex is shown in blue and different 
nucleotide state of actin is indicated in red shadings. The cycle starts with the 
activation of Arp2/3 by the VCA domains of WASp, which promotes association to 
the actin filament (Step 1). ATP-G-actin is nucleated and a daughter filament 
elongates (steps 2 and 3). Filament aging weakens the interaction between Arp2/3 and 
actin filaments, allowing branch disassembly (steps 4 and 5). Arp2/3 is released and 
recycled (step 6).
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Arp2/3 is directly regulated by members of the Wiskott-Aldrich syndrome 
(WASp)/Scar protein family (Machesky et al., 1999).
The WASp/Scar family includes WASp of 53-kDa, neuronal WASp (N- 
WASp) of 55-kDa, and the 62-kDa WASP family Verprolin-homologueous protein 
(WAVE, which is the vertebrate homologue of Scar). This protein family interacts 
with a variety of molecules known to influence cytoskeletal dynamics, and is 
considered to integrate diverse cellular signals (e.g. growth factor receptor signals) 
through their functional domains with the actin cytoskeleton. The WASp/Scar 
proteins share similar C-terminal WASp homology 2 (WH2), VCA (Verproline 
homology, Cofilin homology, Acidic) domains and proline-rich central regions. 
However, differences are seen in the N-terminus (e.g. N-WASp carries an IQ domain 
and WAVE lacks a WH1 domain found in WASp and N-WASp) (Zigmond, 2000). 
The VCA domain is sufficient to bind the Arp2/3 complex and to activate its 
nucleation activity (Machesky et al., 1999; Rohatgi et al., 1999). It has been shown for 
N-WASp that the N-terminal WH1 domain interacts with the C-terminal VCA domain 
and inhibits the activation of Arp2/3. In addition, the Rho family GTPase Cdc42 can 
bind to the WH1 domain and block the intramolecular interaction between the C- and 
N- termini, resulting in activation of Arp2/3 (Rohatgi et al., 2000). However, whether 
this regulatory mechanism also occurs in the other members of the WASp/Scar family 
is not known. The proline-rich region binds multiple src-homology 3 (SH3) domain- 
containing proteins (Bunnell et al., 1996; Finan et al., 1996). N-WASp and WASp 
carry a GTPase-binding domain (GBD), which confers the ability to interact with 
activated Cdc42 and Rac (Symons et al., 1996). Cdc42 and Rac belong to the Rho 
family of GTPases, which are known to influence different aspects of the actin 
cytoskeleton (e.g. formation of stress fibres, filopodia and ruffles). On the other hand,
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WAVE lacks a GBD, although it was shown to be regulated by Rac (Miki et al., 
1998b). Another difference between WAVE, WASp and N-WASp is the presence of a 
WH1 domain in the latter two proteins, which can bind phosphatidyl inositol (4,5)- 
bisphosphate (PIP2). PIP2 activates WAVE and WASp, hence activating Arp2/3 
nucleation activity (Miki et al., 1996).
1.3.3 Severing, capping and uncapping actin filaments
Actin polymerization can occur in vivo by nucleation of unpolymerized actin 
(e.g. mediated by Arp2/3) or by the creation of free barbed ends by actin severing 
proteins, or by the release of capping proteins from the tip of the filament. Gelsolin, 
and capping protein (CapZ) are two well studied proteins that cap barbed ends of actin 
filaments (Bryan and Coluccio, 1985; Caldwell et al., 1989) and are both released 
upon polyphosphoinositide binding (e.g. PIP2) (Janmey and Stossel, 1987; Schafer et 
al., 1996),
CapZ is a heterodimeric protein that is composed of an a-subunit of 33-kDa 
and a p-subunit of 31-kDa. Association of CapZ with actin filaments prevents the 
exchange of actin subunits from the barbed end. CapZ also attaches actin filaments to 
other structures such as cell-cell junctions and the Z-line of skeletal and cardiac 
muscle, and CapZ help the formation of actin nuclei for the elongation of filaments 
(Casella et al., 1987; Casella et al., 1986; Casella and Torres, 1994).
Gelsolin is an 80-kDa protein able to break and cap actin filaments, thus 
producing short filaments that cannot elongate (Sun et al., 1999). The release of 
intracellular Ca+ upon an external stimulus activates gelsolin to sever actin filaments 
(Yin et al., 1980) and cap their barbed ends. In addition, membrane-bound PIP2 can 
remove the gelsolin cap and contribute to actin polymerization (Hartwig et al., 1995).
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One gelsolin isoform is released into the blood stream, where it severs and caps actin 
filaments released into the circulation, in order to be ultimately removed from the 
circulation by the liver (Lind et al., 1986). However, severing and (un)capping 
processes alone are not sufficient to drive actin polymerization. Pools of actin 
monomers have to be permanently available in order to be incorporated at the barbed 
ends.
1.3.4 Actin-monomer-binding proteins
Non-muscle cells maintain a high concentration of unpolymerized actin (^100 
pM) and the vast majority is bound to ATP. Interestingly, 100 pM of actin monomers 
in physiological concentrations of salt polymerize rapidly in vitro, leaving only 0.1 
pM of monomers (known as the critical concentration). Hence, a regulatory 
mechanism must exist in cells to maintain the high levels of actin monomers (Pollard 
et al., 2000). Indeed, actin-monomer-binding proteins regulate actin polymerization 
and depolymerization by sequestering G-actin, exchanging the nucleotide ADP for 
ATP and delivering the monomer to the barbed end of the filament.
The best-characterized actin-monomer-binding proteins are the actin 
depolymerization factor (ADF) /cofilin, twinfilin, WASp/Scar (see Sec. 1.3.2), 
thymosin and profilin. ADFs and cofilins, both of 18.5-kDa are able to increase actin 
filament turnover by binding ADP-actin monomers and increasing the dissociation 
rate of actin from the pointed ends of the filaments, but not from the barbed ends 
(Carlier et al., 1997). In addition, ADF/cofilins can sever (Nishida et al., 1984) and 
bind actin filaments (Hayden et al., 1993). ADF and cofilins can bind ADP-actin 
monomers with greater affinity than ATP-actin, and have greater affinity for ADP- 
actin filaments than ATP-actin filaments or ADP+Pi-actin filaments (Maciver and
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Weeds, 1994). ADF/cofilins are also present at the contractile ring during cytokinesis 
and are necessary for its depolymerization (Gunsalus et al., 1995; Nagaoka et al., 
1995), and the Drosophila cofilin homologue has been shown to be essential for cell 
division (Gunsalus et al., 1995).
Twinfilin is a 44-kDa protein that sequesters actin monomers in a 1:1 manner 
and binds ADP-actin preferentially, inhibiting the exchange of ADP for ATP (Goode 
et al., 1998) and thus affecting actin polymerization. In addition, twinfilin possesses 
two ADF/cofilin-like domains, which are ~20% homologueous to ADF/cofilin and are 
important for G-actin binding (Lappalainen et al., 1998; Palmgren et al., 2001). The 
actin-monomer-binding activity can be regulated by PIP2, and binding of PIP2 in vitro 
downregulates the actin-monomer-sequestering activity of twinfilin.
Thymosins are small proteins of 5-kDa that sequester G-actin through their 
WH2 domain (Paunola et al., 2002) and prevent the delivery of actin monomers to the 
barbed end of the filaments. Profilins, with an approximate molecular weight of 19- 
kDa, also sequester G-actin, but unlike thymosins they can bind the barbed end of the 
actin filament and promote filament polymerization (Tilney et al., 1983).
Actin-monomer-binding proteins can distinguish between ATP-actin and 
ADP-actin (e.g. thymosin binds about 50-fold more strongly to ATP-actin than to 
ADP-actin) (Carlier et al., 1993) and they can also compete for the same actin-binding 
site (e.g. thymosin-p4 competes with profilin for binding to overlapping sites on 
actin) (Pantaloni and Carlier, 1993; Schutt et al., 1993). It has been shown that actin 
bound to thymosin does not polymerize, but that profilin can displace thymosin from 
actin monomers and transport actin to the barbed end of actin filaments. A similar 
mechanism is observed between ADF/cofilin and twinfilin, which share similar actin- 
binding sites. Depolymerized ADP-actin monomers could be delivered to twinfilin by
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ADF/cofilin, and twinfilin may keep the actin monomers in their ADP form near the 
barbed ends (Goode et al., 1998). Twinfilin could release the ADP-actin monomer at 
rapid polymerization sites where the actin monomer would undergo nucleotide 
exchange and assemble into the plus end of the filament either spontaneously or 
mediated by profilin (Palmgren et al., 2002). Thus, actin-monomer-binding proteins 
can be classified into monomer-sequestering proteins (thymosin and twinfilin), ATP- 
monomer-binding proteins (profilin and thymosin), ADP-monomer-binding proteins 
(ADF/cofilin, twinfilin), depolymerization promoters (ADF/cofilin), and actin-ADP 
nucleotide exchange inhibitors (twinfilin and cofilin). The correct spatial and temporal 
organization of actin filaments and of their regulatory proteins is essential for the 
correct function of eukaryotic cells. In contrast to the dynamic pool of actin filaments 
at the cell cortex or in lamellipodia, a less dynamic and more stable pool of actin 
filaments is distinguished in many cultured cells and tissues. These filaments can be 
found packed into stress fibres and distribute through the cytoplasm.
1.3.5 Properties of stable actin filaments
Highly dynamic actin filaments and low dynamic actin-rich structures can 
coexist in migrating cells (e.g. stress fibres behind the leading edge of migrating 
cells), and many cells form specialized actin-based structures that are relatively stable 
(e.g. myofibrils of the striated muscle and the long bundles of actin filaments in 
microvilli of the intestinal brush border). The half-life of fluorescence recovery after 
photobleaching (FRAP) for rhodamine-labelled muscle actin in striated muscles is 
~60 min (Shimada et al., 1997), which is relatively slow compared to other actin 
structures, such as stress fibres (~5-10 min) (Kreis et al., 1979) or lamellipodia in 
migrating cells (~0.5-3.0 min) (Theriot and Mitchison, 1991). A variety of ABPs are
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able to stabilize actin filaments (e.g. calponin), anchor the actin cytoskeleton the cell 
membrane (e.g. a-actinin and spectrin), affect the elasticity of the actin network (e.g. 
spectrin), crosslink actin filaments (e.g. fimbrin, fascin and a-actinin) or displace 
actin filaments (e.g. myosin).
Formation of stable actin filaments into higher order structures is controlled by 
proteins that can crosslink and bundle actin filaments (e.g. a-actinin, spectrin and 
fimbrin), and many of these proteins share a conserved domain that mediates their 
association with actin filaments (Puius et al., 1998). This actin-binding domain (ABD) 
consists of a tandem repeat of two calponin-homology (CH) domains (Gimona et al., 
2002). Crosslinking and bundling proteins utilize two ABDs to connect actin 
filaments. Fimbrin is a 70-kDa protein that carries two ABDs arranged in tandem on 
the same polypeptide chain (Goldsmith et al., 1997), which allows the formation of 
tightly packed bundles of actin filaments (Matsudaira, 1994). In contrast, many other 
crosslinking proteins, such as a-actinin, carry a single ABD; however, these proteins 
form dimers, thus exposing two ABDs, which are necessary to crosslink or bundle 
actin filaments (Broderick and Winder, 2002). It is known that the distance between 
two ABDs of an actin crosslinking protein correlates with the structural properties of 
the actin filament network (Tseng et al., 2005). The ABDs of filamin are separated by 
a flexible arm and crosslink actin filaments mostly into an orthogonal network (Tseng 
et al., 2004), while a-actinin ABDs are separated by a 30-40 nm spacer, and crosslink 
and bundle actin filaments into tight, parallel arrays (Meyer and Aebi, 1990; 
Wachsstock et al., 1993). In addition, the formation of different types of actin filament 
arrays are concentration dependent. Low concentrations of a-actinin induce formation 
of loosely packed actin filaments, whereas high concentrations induce tightly packed 
parallel arrays of actin filaments.
a-Actinin belongs to the spectrin superfamily of proteins, which includes 
dystrophin, utrophin and spectrin (Baron et al., 1987; Davison and Critchley, 1988; 
Koenig et al., 1988). Members of the spectrin superfamily have an ABD at their N- 
terminus that is followed by multiple spectrin repeats, which are responsible for 
protein dimerization. These repeats vary in length among the members of the 
superfamily, and they determine the flexibility of the ABP and the nature of the actin 
filament network; at the C-terminus a calcium-binding EF-hand domain is commonly 
present (Broderick and Winder, 2002). While a-actinin forms antiparallel 
homodimers, spectrin is found as heterotetramers of a- and (3-spectrin; no 
dimerization has been found for dystrophin (Chan and Kunkel, 1997; Davison et al., 
1989; Kahana and Gratzer, 1991). Each a-actinin subunit has a molecular weight of 
~103-kDa, and four genetic isoforms have been described, each found within specific 
tissues. a-Actinin-1 and 4 are mainly found in non-muscle cells and are sensitive to 
regulation by Ca2+(Burridge and Feramisco, 1981). They are both associated with 
focal adhesions and stress fibres, however, in motile cells, a-actinin-4 is also found in 
ruffles (Araki et al., 2000; Edlund et al., 2001; Pavalko and Burridge, 1991). In 
contrast, a-actinin-2 and 3 are found in skeletal, cardiac and smooth muscle cells and 
are insensitive to Ca2+ (Beggs et al., 1992).
Spectrin is an antiparallel heterodimer that is composed of (3- and a-spectrin 
with molecular weights of 246-kDa and 280-kDa, respectively, and it has been 
extensively characterized in erythrocytes (Stokke et al., 1986), where the flexibility of 
spectrin contributes to the inherent deformability of red blood cells (Elgsaeter et al., 
1986). Mutations in spectrin are associated with hereditary haemolytic anaemia 
(Delaunay and Dhermy, 1993; Wichterle et al., 1996) where red blood cell shape is 
abnormal and the cells are sensitive to haemolysis. In contrast to a-actinin, spectrin
also possesses a pleckstrin-homology (PH) and SH3 domains, which allow binding to 
membrane lipids and interactions with proline-rich regions, respectively (Chakrabarti 
et al., 2006). Although the actin-binding activity of spectrins from erythrocytes is 
insensitive to Ca2+ regulation, the ability to bind actin filaments in other cells is 
modulated by Ca2+(Dubreuil et al., 1991; Fishkind et al., 1987; Wallis et al., 1992).
Dystrophin is a 427-kDa protein (Dp427) (Koenig et al., 1988), and it carries 
an ABD at its N-terminus, followed by 24 spectrin-like repeats. Mutations in the 
dystrophin gene are associated with many muscular diseases such as Duchenne and 
Becker muscular dystrophy where the regenerative capacity of the muscle is lost. 
There are several alternatively spliced isoforms of dystrophin such as Dp260 
(D'Souza et al., 1995), Dpl40 (Lidov et al., 1995), Dpi 16 (Byers et al., 1993) and 
Dp71 (Blake et al., 1992). Dystrophin isoforms are specifically expressed in different 
tissues. Unlike the other members of the spectrin family, dystrophin does not bundle 
or crosslink actin filaments (Rybakova et al., 1996). The C-terminus contains a WW 
domain, which binds to proline-rich substrates and allows interactions with other 
proteins. Utrophin is a protein of 395-kDa, and it is a genetic isoform of dystrophin 
with major differences in the C-terminus (Love et al., 1989).
Besides the well-characterized spectrin protein family other crosslinking and 
bundling proteins have been described that posses an ABD formed by two CH 
domains. These proteins include filamin, plectin, cortexillin, smoothelin, fimbrin and 
fascin, which are reviewed briefly below.
Filamin is a parallel homodimer and each subunit has a molecular weight of 
280-kDa. Filamin subunits consist of an N-terminal ABD followed by a rod-shape 
domain, which is important for dimerization (Weihing, 1988). There are three genetic 
isoforms, FLNA, FLNB and FLNC. Many human diseases have been related to
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mutations in FLNA and FLNB, which cause abnormal development of brain, bone, 
the cardiovascular system and many other organs (Eksioglu et al., 1996; Kakita et al., 
2002; Robertson et al., 2003). Dimerization of filamins through the last C-terminal 
repeat allows the formation of a V-shaped flexible structure (Gorlin et al., 1990). The 
flexibility of filamins allows it to crosslink actin filaments orthogonally (Weihing,
1985).
Plectin is a functionally versatile protein, which binds to several components 
of the cytoskeleton such as actin, intermediate filaments and microtubules (Foisner et 
al., 1991; Wiche et al., 1982; Yang et al., 1996). The molecular weights of plectin 
isoforms vary from 507-kDa to 527-kDa and they carry an ABD at their N-termini, 
which allows binding to actin filaments.
Cortexillins also possess an ABD at their N-termini, but unlike the spectrins, 
filamins and plectins, they also posses a second strong actin-binding site (ABS) at 
their C-termini (Stock et al., 1999) which is not related to CH domains. Cortexillins 
are made of parallel heterodimers of cortexillin I and II isoforms (Faix et al., 1996) 
with an approximate molecular weights of 50-kDa each.
Smoothelins share similar functions with the other actin crosslinkers and 
bundlers, however a major difference is observed in its single CH domain, which is 
positioned at the C-terminus of the protein (Gimona et al., 2002; Niessen et al., 2004). 
Two spliced isoforms have been described so far with molecular weights of 59-kDa 
(smoothelin A) and 110-kDa (smoothelin B). Smoothelins that lack the CH domain 
still bind actin filaments, and thus it is thought that more than one ABS exists on the 
molecule.
Fascins are 55-58-kDa proteins that form tight and stable bundles of actin 
filaments (Otto et al., 1979; Saishin et al., 1997). Three genetic isoforms are found in
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humans, fascin-1, -2 and -3. All of these contain an ABD at their C-terminus and a 
second unrelated ABS at their N-terminus. Fascin-1 is expressed in most tissues, 
whilst fascin-2 is expressed in the retina, and fascin-3 expression is largely restricted 
to the testis (Kureishy et al., 2002). Fascins colocalize with filopodia and it is believed 
that they are key elements of filopodia formation. The inclusion of fascins with actin 
in liposomes causes the extension of straight and rigid projections from their surface 
(Honda et al., 1999).
1.4 Signalling to the actin cytoskeleton
Cells have evolved complex mechanisms to sense and respond to the external 
environment. Whether keratocytes migrate towards wound areas or neutrophils cross 
endothelial cells to escape from the blood stream, both need massive re-arrangements 
of the actin cytoskeleton to perform these tasks (Radice, 1980; Zigmond and 
Lauffenburger, 1986). Hence, cells can adapt the actin cytoskeleton according to their 
needs. External signals, such as growth factors, pro-inflammatory molecules or 
components of the extracellular matrix can bind to membrane receptors that can then 
lead to the activations of specific signalling pathways. Signalling pathways involve 
enzymes that catalyze reactions such as (de)phosphorylation and nucleotide exchange. 
It is possible to distinguish between an input and an output control. The input control 
determines the temporal and spatial activation of the enzymes. The output control 
determines the spatial and temporal activation of their downstream partners.
ABPs, which are the major actin-regulatory proteins, are targeted by many 
cell-signalling proteins and molecules (e.g. PIP2, Ca2+ and PKC) that can activate or 
inactive them. The activation of many signalling pathways results in Ca2+ release and 
the generation of different types of phosphatidylinositols (Pis). Both tightly regulate
2 8
the assembly of actin polymers. Ca2+ and Pis can control the activity of capping, 
monomer-binding and severing proteins. The capping and monomer-binding proteins 
profilin and CapZ contain a PIP2 binding site and binding of the phosphoinositide 
inhibits their association with actin (Heiss and Cooper, 1991). On the other hand, the 
severing activity of gelsolin can be regulated either by Ca2+ or by PIP2 (Bearer, 1991; 
Janmey et al., 1987; Yin and Janmey, 2003). Binding of Ca2+ to gelsolin activates its 
severing activity, in contrast to PIP2, which inhibits gelsolin activity. Also ADF and 
cofilin activities are inhibited by phosphatidylinositols (Yonezawa et al., 1990). Ca2+ 
and Pis also regulate actin crosslinking proteins. a-Actinin crosslinking activity is 
enhanced by PIP and PIP2, and a-actinin-1 and -4 activity is dependent on Ca2+ 
(Fukami et al., 1992; Noegel et al., 1987; Witke et al., 1993). In contrast, filamin 
actin-crosslinking activity is reduced by PIP and PIP2 (Furuhashi et al., 1992).
1.4.1 Organization of the actin cytoskeleton by Rho GTPases
The Rho GTPase protein family is known to be a key regulator of signalling 
pathways that link extracellular and intracellular stimuli to the organization of the 
cytoskeleton. Signalling through Rho GTPases can be initiated by activation of many 
different types of plasma membrane receptors (Hall and Nobes, 2000). Rho GTPases 
are key players in the formation of lamellipodia, membrane ruffles, filopodia and of 
stable stress fibres. Rho GTPases cycle between an active GTP-bound form and an 
inactive GDP-bound form. The GTP-bound active form of RhoGTPases activates a 
plethora of downstream effectors. The cycle between the active and inactive state is 
regulated by GDP/GTP exchange factors (GEFs), GTPase-activating proteins (GAPs), 
and guanine nucleotide dissociation inhibitors (GDIs; Fig. 6). GEFs are responsible 
for the conversion of the inactive GDP-bound form of the GTPases to the active GTP-
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Arp2/3 is directly regulated by members of the Wiskott-Aldrich syndrome 
(WASp)/Scar protein family (Machesky et al., 1999).
The WASp/Scar family includes WASp of 53-kDa, neuronal WASp (N- 
WASp) of 55-kDa, and the 62-kDa WASP family Verprolin-homologueous protein 
(WAVE, which is the vertebrate homologue of Scar). This protein family interacts 
with a variety of molecules known to influence cytoskeletal dynamics, and is 
considered to integrate diverse cellular signals (e.g. growth factor receptor signals) 
through their functional domains with the actin cytoskeleton. The WASp/Scar 
proteins share similar C-terminal WASp homology 2 (WH2), VCA (Verproline 
homology, Cofilin homology, Acidic) domains and proline-rich central regions. 
However, differences are seen in the N-terminus (e.g. N-WASp carries an IQ domain 
and WAVE lacks a WH1 domain found in WASp and N-WASp) (Zigmond, 2000). 
The VCA domain is sufficient to bind the Arp2/3 complex and to activate its 
nucleation activity (Machesky et al., 1999; Rohatgi et al., 1999). It has been shown 
for N-WASp that the N-terminal WH1 domain interacts with the C-terminal VCA 
domain and inhibits the activation of Arp2/3. In addition, the Rho family GTPase 
Cdc42 can bind to the WH1 domain and block the intramolecular interaction between 
the C- and N- termini, resulting in activation of Arp2/3 (Rohatgi et al., 2000). 
However, whether this regulatory mechanism also occurs in the other members of the 
WASp/Scar family is not known. The proline-rich region binds multiple src- 
homology 3 (SH3) domain-containing proteins (Bunnell et al., 1996; Finan et al., 
1996). N-WASp and WASp carry a GTPase-binding domain (GBD), which confers 
the ability to interact with activated Cdc42 and Rac (Symons et al., 1996). Cdc42 and 
Rac belong to the Rho family of GTPases, which are known to influence different 
aspects of the actin cytoskeleton (e.g. formation of stress fibres, filopodia and ruffles).
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On the other hand, WAVE lacks a GBD, although it was shown to be regulated by 
Rac (Miki et al., 1998b). Another difference between WAVE, WASp and N-WASp is 
the presence of a WH1 domain in the latter two proteins, which can bind 
phosphatidylinositol (4,5)-bisphosphate (PIP2). PIP2 activates WAVE and WASp, 
hence activating Arp2/3 nucleation activity (Miki et al., 1996).
1.3.3 Severing, capping and uncapping actin filaments
Actin polymerization can occur in vivo by nucleation of unpolymerized actin 
(e.g. mediated by Arp2/3) or by the creation of free barbed ends by actin severing 
proteins, or by the release of capping proteins from the tip of the filament. Gelsolin, 
and capping protein (CapZ) are two well studied proteins that cap barbed ends of actin 
filaments (Bryan and Coluccio, 1985; Caldwell et al., 1989) and are both released 
upon polyphosphoinositide binding (e.g. PIP2) (Janmey and Stossel, 1987; Schafer et 
al., 1996),
CapZ is a heterodimeric protein that is composed of an a-subunit of 33-kDa 
and a |3-subunit of 31-kDa. Association of CapZ with actin filaments prevents the 
exchange of actin subunits from the barbed end. CapZ also attaches actin filaments to 
other structures such as cell-cell junctions and the Z-line of skeletal and cardiac 
muscle, and CapZ help the formation of actin nuclei for the elongation of filaments 
(Casella et al., 1987; Casella et al., 1986; Casella and Torres, 1994).
Gelsolin is an 80-kDa protein able to break and cap actin filaments, thus 
producing short filaments that cannot elongate (Sun et al., 1999). The release of 
intracellular Ca+ upon an external stimulus activates gelsolin to sever actin filaments 
(Yin et al., 1980) and cap their barbed ends. In addition, membrane-bound PIP2 can 
remove the gelsolin cap and contribute to actin polymerization (Hartwig et al., 1995).
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One gelsolin isoform is released into the blood stream, where it severs and caps actin 
filaments released into the circulation, in order to be ultimately removed from the 
circulation by the liver (Lind et al., 1986). However, severing and (un)capping 
processes alone are not sufficient to drive actin polymerization. Pools of actin 
monomers have to be permanently available in order to be incorporated at the barbed 
ends.
1.3.4 Actin-monomer-binding proteins
Non-muscle cells maintain a high concentration of unpolymerized actin (^100 
pM) and the vast majority is bound to ATP. Interestingly, 100 pM of actin monomers 
in physiological concentrations of salt polymerize rapidly in vitro, leaving only 0.1 
pM of monomers (known as the critical concentration). Hence, a regulatory 
mechanism must exist in cells to maintain the high levels of actin monomers (Pollard 
et al., 2000). Indeed, actin-monomer-binding proteins regulate actin polymerization 
and depolymerization by sequestering G-actin, exchanging the nucleotide ADP for 
ATP and delivering the monomer to the barbed end of the filament.
The best-characterized actin-monomer-binding proteins are the actin 
depolymerization factor (ADF) /cofilin, twinfilin, WASp/Scar (see Sec. 1.3.2), 
thymosin and profilin. ADFs and cofilins, both of 18.5-kDa are able to increase actin 
filament turnover by binding ADP-actin monomers and increasing the dissociation 
rate of actin from the pointed ends of the filaments, but not from the barbed ends 
(Carlier et al., 1997). In addition, ADF/cofilins can sever (Nishida et al., 1984) and 
bind actin filaments (Hayden et al., 1993). ADF and cofilins can bind ADP-actin 
monomers with greater affinity than ATP-actin, and have greater affinity for ADP- 
actin filaments than ATP-actin filaments or ADP+Pi-actin filaments (Maciver and
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Weeds, 1994). ADF/cofilins are also present at the contractile ring during cytokinesis 
and are necessary for its depolymerization (Gunsalus et al., 1995; Nagaoka et al., 
1995), and the Drosophila cofilin homologue has been shown to be essential for cell 
division (Gunsalus et al., 1995).
Twinfilin is a 44-kDa protein that sequesters actin monomers in a 1:1 manner 
and binds ADP-actin preferentially, inhibiting the exchange of ADP for ATP (Goode 
et al., 1998) and thus affecting actin polymerization. In addition, twinfilin possesses 
two ADF/cofilin-like domains, which are ~20% homologueous to ADF/cofilin and are 
important for G-actin binding (Lappalainen et al., 1998; Palmgren et al., 2001). The 
actin-monomer-binding activity can be regulated by PIP2, and binding of PIP2 in vitro 
downregulates the actin-monomer-sequestering activity of twinfilin.
Thymosins are small proteins of 5-kDa that sequester G-actin through their 
WH2 domain (Paunola et al., 2002) and prevent the delivery of actin monomers to the 
barbed end of the filaments. Profilins, with an approximate molecular weight of 19- 
kDa, also sequester G-actin, but unlike thymosins they can bind the barbed end of the 
actin filament and promote filament polymerization (Tilney et al., 1983).
Actin-monomer-binding proteins can distinguish between ATP-actin and 
ADP-actin (e.g. thymosin binds about 50-fold more strongly to ATP-actin than to 
ADP-actin) (Carlier et al., 1993) and they can also compete for the same actin-binding 
site (e.g. thymosin-(34 competes with profilin for binding to overlapping sites on 
actin) (Pantaloni and Carlier, 1993; Schutt et al., 1993). It has been shown that actin 
bound to thymosin does not polymerize, but that profilin can displace thymosin from 
actin monomers and transport actin to the barbed end of actin filaments. A similar 
mechanism is observed between ADF/cofilin and twinfilin, which share similar actin- 
binding sites. Depolymerized ADP-actin monomers could be delivered to twinfilin by
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ADF/cofilin, and twinfilin may keep the actin monomers in their ADP form near the 
barbed ends (Goode et al., 1998). Twinfilin could release the ADP-actin monomer at 
rapid polymerization sites where the actin monomer would undergo nucleotide 
exchange and assemble into the plus end of the filament either spontaneously or 
mediated by profilin (Palmgren et al., 2002). Thus, actin-monomer-binding proteins 
can be classified into monomer-sequestering proteins (thymosin and twinfilin), ATP- 
monomer-binding proteins (profilin and thymosin), ADP-monomer-binding proteins 
(ADF/cofilin, twinfilin), depolymerization promoters (ADF/cofilin), and actin-ADP 
nucleotide exchange inhibitors (twinfilin and cofilin). The correct spatial and temporal 
organization of actin filaments and of their regulatory proteins is essential for the 
correct function of eukaryotic cells. In contrast to the dynamic pool of actin filaments 
at the cell cortex or in lamellipodia, a less dynamic and more stable pool of actin 
filaments is distinguished in many cultured cells and tissues. These filaments can be 
found packed into stress fibres and distribute through the cytoplasm.
1.3.5 Properties of stable actin filaments
Highly dynamic actin filaments and low dynamic actin-rich structures can 
coexist in migrating cells (e.g. stress fibres behind the leading edge of migrating 
cells), and many cells form specialized actin-based structures that are relatively stable 
(e.g. myofibrils of the striated muscle and the long bundles of actin filaments in 
microvilli of the intestinal brush border). The half-life of fluorescence recovery after 
photobleaching (FRAP) for rhodamine-labelled muscle actin in striated muscles is 
~60 min (Shimada et al., 1997), which is relatively slow compared to other actin 
structures, such as stress fibres (~5-10 min) (Kreis et al., 1979) or lamellipodia in 
migrating cells (~0.5-3.0 min) (Theriot and Mitchison, 1991). A variety of ABPs are
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able to stabilize actin filaments (e.g. calponin), anchor the actin cytoskeleton the cell 
membrane (e.g. a-actinin and spectrin), affect the elasticity of the actin network (e.g. 
spectrin), crosslink actin filaments (e.g. fimbrin, fascin and a-actinin) or displace 
actin filaments (e.g. myosin).
Formation of stable actin filaments into higher order structures is controlled by 
proteins that can crosslink and bundle actin filaments (e.g. a-actinin, spectrin and 
fimbrin), and many of these proteins share a conserved domain that mediates their 
association with actin filaments (Puius et al., 1998). This actin-binding domain (ABD) 
consists of a tandem repeat of two calponin-homology (CH) domains (Gimona et al.,
2002). Crosslinking and bundling proteins utilize two ABDs to connect actin 
filaments. Fimbrin is a 70-kDa protein that carries two ABDs arranged in tandem on 
the same polypeptide chain (Goldsmith et al., 1997), which allows the formation of 
tightly packed bundles of actin filaments (Matsudaira, 1994). In contrast, many other 
crosslinking proteins, such as a-actinin, carry a single ABD; however, these proteins 
form dimers, thus exposing two ABDs, which are necessary to crosslink or bundle 
actin filaments (Broderick and Winder, 2002). It is known that the distance between 
two ABDs of an actin crosslinking protein correlates with the structural properties of 
the actin filament network (Tseng et al., 2005). The ABDs of filamin are separated by 
a flexible arm and crosslink actin filaments mostly into an orthogonal network (Tseng 
et al., 2004), while a-actinin ABDs are separated by a 30-40 nm spacer, and crosslink 
and bundle actin filaments into tight, parallel arrays (Meyer and Aebi, 1990; 
Wachsstock et al., 1993). In addition, the formation of different types of actin filament 
arrays are concentration dependent. Low concentrations of a-actinin induce formation 
of loosely packed actin filaments, whereas high concentrations induce tightly packed 
parallel arrays of actin filaments.
a-Actinin belongs to the spectrin superfamily of proteins, which includes 
dystrophin, utrophin and spectrin (Baron et al., 1987; Davison and Critchley, 1988; 
Koenig et al., 1988). Members of the spectrin superfamily have an ABD at their N- 
terminus that is followed by multiple spectrin repeats, which are responsible for 
protein dimerization. These repeats vaiy in length among the members of the 
superfamily, and they determine the flexibility of the ABP and the nature of the actin 
filament network; at the C-terminus a calcium-binding EF-hand domain is commonly 
present (Broderick and Winder, 2002). While a-actinin forms antiparallel 
homodimers, spectrin is found as heterotetramers of a- and (3-spectrin; no 
dimerization has been found for dystrophin (Chan and Kunkel, 1997; Davison et al., 
1989; Kahana and Gratzer, 1991). Each a-actinin subunit has a molecular weight of 
~103-kDa, and four genetic isoforms have been described, each found within specific 
tissues. a-Actinin-1 and 4 are mainly found in non-muscle cells and are sensitive to 
regulation by Ca2+ (Burridge and Feramisco, 1981). They are both associated with 
focal adhesions and stress fibres, however, in motile cells, a-actinin-4 is also found in 
ruffles (Araki et al., 2000; Edlund et al., 2001; Pavalko and Burridge, 1991). In 
contrast, a-actinin-2 and 3 are found in skeletal, cardiac and smooth muscle cells and 
are insensitive to Ca2+ (Beggs et al., 1992).
Spectrin is an antiparallel heterodimer that is composed of |3- and a-spectrin 
with molecular weights of 246-kDa and 280-kDa, respectively, and it has been 
extensively characterized in erythrocytes (Stokke et al., 1986), where the flexibility of 
spectrin contributes to the inherent deformability of red blood cells (Elgsaeter et al.,
1986). Mutations in spectrin are associated with hereditary haemolytic anaemia 
(Delaunay and Dhermy, 1993; Wichterle et al., 1996) where red blood cell shape is 
abnormal and the cells are sensitive to haemolysis. In contrast to a-actinin, spectrin
also possesses a pleckstrin-homology (PH) and SH3 domains, which allow binding to 
membrane lipids and interactions with proline-rich regions, respectively (Chakrabarti 
et al., 2006). Although the actin-binding activity of spectrins from erythrocytes is 
insensitive to Ca2+ regulation, the ability to bind actin filaments in other cells is 
modulated by Ca2+(Dubreuil et al., 1991; Fishkind et al., 1987; Wallis et al., 1992).
Dystrophin is a 427-kDa protein (Dp427) (Koenig et al., 1988), and it carries 
an ABD at its N-terminus, followed by 24 spectrin-like repeats. Mutations in the 
dystrophin gene are associated with many muscular diseases such as Duchenne and 
Becker muscular dystrophy where the regenerative capacity of the muscle is lost. 
There are several alternatively spliced isoforms of dystrophin such as Dp260 
(D'Souza et al., 1995), Dpl40 (Lidov et al., 1995), Dpi 16 (Byers et al., 1993) and 
Dp71 (Blake et al., 1992). Dystrophin isoforms are specifically expressed in different 
tissues. Unlike the other members of the spectrin family, dystrophin does not bundle 
or crosslink actin filaments (Rybakova et al., 1996). The C-terminus contains a WW 
domain, which binds to proline-rich substrates and allows interactions with other 
proteins. Utrophin is a protein of 395-kDa, and it is a genetic isoform of dystrophin 
with major differences in the C-terminus (Love et al., 1989).
Besides the well-characterized spectrin protein family other crosslinking and 
bundling proteins have been described that posses an ABD formed by two CH 
domains. These proteins include filamin, plectin, cortexillin, smoothelin, fimbrin and 
fascin, which are reviewed briefly below.
Filamin is a parallel homodimer and each subunit has a molecular weight of 
280-kDa. Filamin subunits consist of an N-terminal ABD followed by a rod-shape 
domain, which is important for dimerization (Weihing, 1988). There are three genetic 
isoforms, FLNA, FLNB and FLNC. Many human diseases have been related to
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mutations in FLNA and FLNB, which cause abnormal development of brain, bone, 
the cardiovascular system and many other organs (Eksioglu et a l, 1996; Kakita et al., 
2002; Robertson et al., 2003). Dimerization of filamins through the last C-terminal 
repeat allows the formation of a V-shaped flexible structure (Gorlin et al., 1990). The 
flexibility of filamins allows it to crosslink actin filaments orthogonally (Weihing, 
1985).
Plectin is a functionally versatile protein, which binds to several components 
of the cytoskeleton such as actin, intermediate filaments and microtubules (Foisner et 
al., 1991; Wiche et al., 1982; Yang et al., 1996). The molecular weights of plectin 
isoforms vary from 507-kDa to 527-kDa and they carry an ABD at their N-termini, 
which allows binding to actin filaments.
Cortexillins also possess an ABD at their N-termini, but unlike the spectrins, 
filamins and plectins, they also posses a second strong actin-binding site (ABS) at 
their C-termini (Stock et al., 1999) which is not related to CH domains. Cortexillins 
are made of parallel heterodimers of cortexillin I and II isoforms (Faix et al., 1996) 
with an approximate molecular weights of 50-kDa each.
Smoothelins share similar functions with the other actin crosslinkers and 
bundlers, however a major difference is observed in its single CH domain, which is 
positioned at the C-terminus of the protein (Gimona et al., 2002; Niessen et al., 2004). 
Two spliced isoforms have been described so far with molecular weights of 59-kDa 
(smoothelin A) and 110-kDa (smoothelin B). Smoothelins that lack the CH domain 
still bind actin filaments, and thus it is thought that more than one ABS exists on the 
molecule.
Fascins are 55-58-kDa proteins that form tight and stable bundles of actin 
filaments (Otto et al., 1979; Saishin et al., 1997). Three genetic isoforms are found in
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humans, fascin-1, -2 and -3. All of these contain an ABD at their C-terminus and a 
second unrelated ABS at their N-terminus. Fascin-1 is expressed in most tissues, 
whilst fascin-2 is expressed in the retina, and fascin-3 expression is largely restricted 
to the testis (Kureishy et al., 2002). Fascins colocalize with filopodia and it is believed 
that they are key elements of filopodia formation. The inclusion of fascins with actin 
in liposomes causes the extension of straight and rigid projections from their surface 
(Honda et al., 1999).
1.4 Signalling to the actin cytoskeleton
Cells have evolved complex mechanisms to sense and respond to the external 
environment. Whether keratocytes migrate towards wound areas or neutrophils cross 
endothelial cells to escape from the blood stream, both need massive re-arrangements 
of the actin cytoskeleton to perform these tasks (Radice, 1980; Zigmond and 
Lauffenburger, 1986). Hence, cells can adapt the actin cytoskeleton according to their 
needs. External signals, such as growth factors, pro-inflammatory molecules or 
components of the extracellular matrix can bind to membrane receptors that can then 
lead to the activations of specific signalling pathways. Signalling pathways involve 
enzymes that catalyze reactions such as (de)phosphoiylation and nucleotide exchange. 
It is possible to distinguish between an input and an output control. The input control 
determines the temporal and spatial activation of the enzymes. The output control 
determines the spatial and temporal activation of their downstream partners.
ABPs, which are the major actin-regulatory proteins, are targeted by many 
cell-signalling proteins and molecules (e.g. PIP2, Ca2+ and PKC) that can activate or 
inactive them. The activation of many signalling pathways results in Ca2+ release and 
the generation of different types of phosphatidylinositols (Pis). Both tightly regulate
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the assembly of actin polymers. Ca2+ and Pis can control the activity of capping, 
monomer-binding and severing proteins. The capping and monomer-binding proteins 
profilin and CapZ contain a PIP2 binding site and binding of the phosphoinositide 
inhibits their association with actin (Heiss and Cooper, 1991). On the other hand, the 
severing activity of gelsolin can be regulated either by Ca2+ or by PIP2 (Bearer, 1991; 
Janmey et al., 1987; Yin and Janmey, 2003). Binding of Ca2+ to gelsolin activates its 
severing activity, in contrast to PIP2, which inhibits gelsolin activity. Also ADF and 
cofilin activities are inhibited by phosphatidylinositols (Yonezawa et al., 1990). Ca2+ 
and Pis also regulate actin crosslinking proteins. a-Actinin crosslinking activity is 
enhanced by PIP and PIP2, and a-actinin-1 and -4 activity is dependent on Ca2+ 
(Fukami et al., 1992; Noegel et al., 1987; Witke et al., 1993). In contrast, filamin 
actin-crosslinking activity is reduced by PIP and PIP2 (Furuhashi et al., 1992).
1.4.1 Organization of the actin cytoskeleton by Rho GTPases
The Rho GTPase protein family is known to be a key regulator of signalling 
pathways that link extracellular and intracellular stimuli to the organization of the 
cytoskeleton. Signalling through Rho GTPases can be initiated by activation of many 
different types of plasma membrane receptors (Hall and Nobes, 2000). Rho GTPases 
are key players in the formation of lamellipodia, membrane ruffles, filopodia and of 
stable stress fibres. Rho GTPases cycle between an active GTP-bound form and an 
inactive GDP-bound form. The GTP-bound active form of RhoGTPases activates a 
plethora of downstream effectors. The cycle between the active and inactive state is 
regulated by GDP/GTP exchange factors (GEFs), GTPase-activating proteins (GAPs), 
and guanine nucleotide dissociation inhibitors (GDIs; Fig. 6). GEFs are responsible 
for the conversion of the inactive GDP-bound form of the GTPases to the active GTP-
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1
actin cytoskeleton
Figure 6. Scheme of Rho GTPase regulation. GDP-bound Rho GTPases are inactive. 
GDIs inhibit the dissociation of GDP from Rho GTPases. GEFs are able to exchange 
the GDP for a GTP, thus activating Rho GTPases. In contrast, GAPs enhance the 
GTPase activity of Rho GTPases.
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bound form, and consequently GEFs act as Rho GTPase-signalling activators. GAPs 
are able to accelerate the low intrinsic GTPase activity of GTPases, thereby GAPs act 
as Rho GTPase-signalling inactivators. The GDI proteins are capable of inhibiting the 
dissociation of GDP from Rho GTPases, and thus GDIs also act as Rho GTPase- 
signalling inhibitors (Schmidt and Hall, 1998).
The Rho family GTPases in mammalian cells include Ras homology (Rho), 
Ras-related C3 botulinum toxin substrate (Rac) and cell division cycle 42 (Cdc42). 
Their respective isoforms are RhoA, RhoB and RhoC for Rho, Racl, Rac2 and Rac3 
for Rac and, G25K and Cdc42Hs for Cdc42 (Hall and Nobes, 2000). Rac proteins 
regulate actin polymerization at the cell periphery to produce lamellipodia and 
membrane ruffles (Ridley et al., 1992), while Cdc42 proteins are responsible for 
filopodia formation (Kozma et al., 1995). On the other hand, Rho proteins regulate the 
assembly of actin stress fibres (Ridley and Hall, 1992). However, locally restricted 
regulation of actin in specific cell areas is not the result of the activation of the 
signalling pathway by a single protein but rather the result of the output of several 
pathways that are activated in parallel. Indeed, Rho family GTPases coordinate 
cytoskeleton rearrangements in concert and the activation of Cdc42 can lead to 
activation of Rac (Nobes and Hall, 1995).
Rac and Cdc42 proteins can activate WAVE and N-WASp respectively, 
which in turn activate the actin nucleation activity of the Arp2/3 complex (Machesky 
et al., 1999; Miki et al., 1998a; Miki et al., 1998b). Both GTPases can also activate 
LIM kinase 1 and 2 (LIMK1 and LIMK2), which then phosphorylate and inactivate 
cofilin, thus inhibiting actin filament disassembly (Arber et al., 1998). LIM kinase 
carries two LIN-11/ISL1/MEC-3 (LIM) domains, which are important for regulating 
its kinase activity (Nagata et al., 1999). Rac activation has also been reported to
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dissociate gelsolin from the actin filament to promote actin polymerization (Arcaro, 
1998), but this interesting possibility has not been confirmed by others.
Rho induces the formation of actin fibres through several downstream 
effectors including mammalian diaphanous (mDia) and Rho kinase (pl60ROCK) 
(Narumiya et al., 1997; Watanabe et al., 1997). In addition to Rho-mediated stress 
fibre formation, Rho also induces the formation of focal adhesions through 
pl60ROCK (Narumiya et al., 1997). Focal adhesions are specialized adhesive 
structures that link the actin cytoskeleton to membrane proteins that bind to the 
extracellular matrix. pl60ROCK is able to active LIMK2, which in turns 
phosphorylates cofilin. Phosphorylated cofilin dissociates from actin filaments, hence 
allowing actin polymerization (Maekawa et al., 1999). Although mDia was shown to 
interact with profilin and to induce actin polymerization, the exact mechanism 
remains elusive. However it is thought that mDia could recruit profilin to the sites of 
actin polymerization (Frazier and Field, 1997; Watanabe et al., 1997).
Another effector of Rho family GTPases are PI kinases, which are responsible 
for the generation of the Pis (e.g. PIP2 from PIP, and PIP3from PIP2). Rho and Rac 
physically interact and regulate the PI(4)P 5-kinase that is responsible for the major 
generation of PIP2 (Chong et al., 1994; Tolias et al., 1995).
1.5 Contractility of actin filaments
Actin filaments form contractile structures together with myosin and accessory 
proteins such as tropomyosin, which influence cell division in individual cells or 
muscle contractility in multicellular organisms. In striated muscle, actin filaments are 
aligned with myosin filaments in contractile units known as sarcomeres. Based on 
light microscopy observations, a sarcomere shows a light band (termed I-band
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Figure 7. Electron microscopy image of a thin section of rabbit striated muscle (upper 
panel) and a schematic representation with the main components of the sarcomere 
(lower panel) (from Huxley, 1957; Lodish et al., 2003). Actin filaments are aligned 
with myosin filaments in contractile units known as sarcomeres in skeletal and cardiac 
muscle. Actin thin filaments span the I-band and overlap with myosin thick filaments 
in the A-band. a-Actinin, CapZ and filamin are found in the Z-discs.
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because of its isotropic behaviour under polarized light) and a dark band (termed A- 
band because of its anisotropic behaviour). Parallel arrays of actin-containing thin 
filaments span the I-band and overlap with myosin-containing thick filaments in the 
A-band (Clark et al., 2002). Actin-binding proteins, including a-actinin, CapZ and 
filamin are found in a structure termed Z-disc, which forms the lateral boundaries of 
the sarcomeres and where actin filaments are attached through their barbed ends (Fig. 
7). Actin filaments start from the Z-discs, span the I-band and extend toward the 
middle of the sarcomere where they interdigitate with thick filaments in the A-band.
Myosins are motor proteins with the ability to physically displace actin 
filaments (Umemoto and Sellers, 1990), and they constitute a large superfamily of 
proteins. Myosins are encoded by 39 genes in humans and are grouped in 15 distinct 
classes according to their sequence similarities (Coluccio, 2007; Richards and 
Cavalier-Smith, 2005). Three functional domains are shared among myosins: 1) a 
motor domain, which interacts with actin and binds ATP; 2) a neck domain, which 
binds myosin light chains (MLCs); and 3) a tail domain, which is diverse and varies in 
length and sequence among the myosins (Sellers, 2000). The tail domain serves to 
anchor and position the motor domain so that in can interact with actin. Myosin II, 
which is found in muscle and non-muscle cells, is a key player in cell contraction. It 
is a multimeric protein composed of two heavy chains (MHCs) of ~220-kDa and four 
MLCs, two of 20-kDa and two of 17-kDa (Lowey et al., 1969; Weeds and Lowey, 
1971). Essential MLCs (eMLCs) and regulatory MLCs (rMLCs) are important for the 
regulation of the myosin motor activity (Clark et al., 2002). Two functional regions 
can be distinguished in myosin II. The N-terminal region of each MHC and two 
rMLCs make up the myosin head that forms cross-bridges with the actin filament. The 
second functional region is formed by the C-termini of the two MHCs, which contain
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coiled-coil domains involved in myosin polymerization. The head forms the catalytic 
motor domain and contains the binding sites for actin and ATP. Actin activates the 
myosin ATPase activity and the hydrolysis of ATP induces a conformational change 
of the head that results in displacement of actin filaments (this process results in 
muscle contraction). The myosin head returns back to its original conformation after 
the release of ADP (this process results in muscle relaxation). Binding of ATP, its 
hydrolysis and its release by the head can be performed in a cyclic manner, which in 
muscle is translated into contraction and relaxation cycles.
In striated muscle, several proteins can regulate the actomyosin-based 
contraction, which include tropomyosin and troponin (Clark et al., 2002). 
Tropomyosins (TMs) have a molecular weight of ~37-kDa and are formed by two 
polypeptide chains arranged as a parallel coiled-coil rod. TMs derive from four genes, 
TPM1,2, 3 and 4 in humans and at least 40 isoforms are expressed by alternative 
splicing (Gunning et al., 2005). TMs form homodimers and heterodimers that cover 
the length of actin filaments (Tsao et al., 1951). a - and p-TMs are mainly found in 
striated muscle and form part of the contractile machinery (Helfman et al., 1986). On 
the other hand, troponin (Tn) is a heterotrimeric complex that is comprised of a Ca2+- 
binding subunit (TnC), an inhibitory subunit (Tnl) and a tropomyosin-binding subunit 
(TnT) with molecular weights of 18-kDa, 20-kDa and 30-kDa respectively (Westfall 
and Metzger, 2001). Tn and TM work together to regulate the interactions of thin and 
thick filaments (Craig and Lehman, 2001). TMs bind along side of actin filaments and 
block the myosin head-binding sites (Greaser and Gergely, 1971), however, the Tn 
complex can shift TM’s position upon Ca2+ binding by TnC, thus unblocking the 
head-binding sites.
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Another important muscle regulatory protein is tropomodulin (Tmod), which 
has a molecular weight of 40-kDa and regulates actin filament length, organization 
and contractile activity (Littlefield and Fowler, 1998). Tmod caps the pointed ends of 
actin filaments in vitro and in striated muscle, and its capping activity is enhanced by 
TM (Weber et al., 1994).
In smooth muscle, although the molecular mechanism of force generation is 
similar to that in striated muscle, the arrangement of sarcomeres has not been 
observed (Seow and Pare, 2007). Furthermore, the dynamic of the actin cytoskeleton 
in smooth muscle cells is similar to that of non-muscle cells (Gerthoffer, 2005). In 
contrast to striated muscle cells, the actin cytoskeleton of smooth muscle cells is 
prone to be disassembled by depolymerizing toxins such as latrunculin and 
cytochalasin. In addition, many of the proteins that control actin dynamics in non­
muscle cells are also important for smooth muscle contraction (e.g. Rho GTPases). 
Another difference between smooth and striated muscle is observed with the 
components of the contractile apparatus. Although actin, myosin and TM are found in 
both types of muscles, Tmod and Tn have not been found in smooth muscles cells (Ito 
et al., 1995; Sobieszek and Bremel, 1975). Furthermore, the contractile apparatus of 
smooth muscles contains two other regulatory proteins not present in striated muscles. 
These proteins are caldesmon and calponin (Small and Gimona, 1998).
Caldesmon (CAD) is a 93-kDa protein able to regulate the myosin ATPase 
activity. While CAD binds actin filaments via its C-terminal domain, it also possesses 
other domains, which allow the interaction with myosin, TM and the Ca2+-binding 
proteins calmodulin (CaM) and S100 (Gusev, 2001). The presence of Ca2+ and 
binding of CaM or SI00 reverse the inhibitory effect on the ATPase activity of 
myosin.
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Calponin has similar activities to that of CAD. It is a 34-kDa protein and 
interacts with CaM, S100, myosin, TM and CAD (Graceffa et al., 1996; Szymanski 
and Tao, 1993; Takahashi et al., 1988; Vancompernolle et al., 1990; Wills et al.,
1993; Winder and Walsh, 1990a). Calponin inhibits the actin-activated ATPase 
activity of myosin and Ca2+CaM is able to inactivate the inhibitory effect of CaP on 
the ATPases activity of myosin (Abe et al., 1990).
1.6 Calponins
Calponin (CaP) was discovered 22 years ago in an attempt to identify Tn-like 
proteins in smooth muscles (Takahashi et al., 1988; Takahashi et al., 1986). Cardiac 
and skeletal muscle contraction/relaxation are tightly regulated by Ca2+, Tn, TM, 
myosin and actin. Although smooth muscle is also regulated by Ca2+ it does not 
contain Tn. CaP, as well as CAD, were shown to bind actin and to regulate the actin- 
activated myosin ATPase activity in a Ca2+ and CaM dependent manner, thus it was 
suggested that both could play similar, Tn-like functions in smooth muscles. CaP was 
shown to share antigenic properties with the C-terminus of TnT. Over the past two 
decades, CaP has been characterized in greater detail and more is known about its 
function and its isoforms.
1.6.1 Expression, activation and turnover
In mammals, the three CaP genetic isoforms are transcribed in a cell-type- 
specific manner. Basic calponin (hiCaP) is the predominant species in smooth muscle 
cells (SMCs) (Gimona et al., 1990), however it has also been detected in fibroblast, 
platelets (Takeuchi et al., 1991) and sertoli cells (Zhu et al., 2004). HICaP is also 
expressed in other cell types in the context of diverse pathological situations, such as
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epithelial cell sarcoma (Yamamura et al., 1998) and mesangial glomerulonephritis 
(Sugenoya et al., 2002). In tissues and in cultured primary SMCs, hlCaP associates 
with the central (potentially contractile) actin bundles (Danninger and Gimona, 2000), 
and it is excluded from cell matrix adhesion sites. Neutral CaP (h2CaP) expression 
has been detected in both smooth muscle and non-muscle cells (Masuda et al., 1996). 
In cultured human keratinocytes, h2CaP localizes to the cell-cell junctions, whereas 
sub-membranous and cytoplasmic accumulation is seen in eccrine sweat glands and 
myoepithelial cells, respectively. In rat lung alveolar cells, the synthesis and 
degradation of h2CaP is sensitive to mechanical tension, and prevention of h2CaP 
degradation requires myosin Independent cellular contractility (Hossain et al., 2006). 
The specific localization of h2CaP around the nuclei of dividing cells and a significant 
increase in binucleated cells in response to ectopic over-expression of h2CaP suggest 
its involvement in the regulation of cell proliferation and cytokinesis (Hossain et al.,
2003). Over-expression of h2CaP also enhanced endothelial cell migration and wound 
healing in a zebrafish model (Tang et al., 2006). Expression of acidic CaP (h3CaP) 
appears mostly restricted to neuronal tissues, although it has also been detected in 
SMCs and pancreatic cells. In rat brain, h3CaP accumulates specifically in glial cells 
and astrocytes of the cortex, hippocampus and cerebellum, and in the choroid plexus 
(Applegate et al., 1994; Ferhat et al., 1996; Represa et al., 1995). The Ca2+-dependent 
cysteine protease m-calpain cleaves unbound h3CaP in vitro (Yoshimoto et al.,
2000a).
All CaP variants share a considerable degree of sequence homology 
throughout their first 273 amino-acids, while they differ completely in their C- 
terminal regions (Fig. 8). These differences give rise to the variations in molecular
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Figure 8 . Sequence alignment of the three mouse calponin isoforms used in this 
thesis. All three CaPs share a high degree of sequence similarity (highlighted in blue) 
except for their C-terminal tails, which start after Cys275.
Table 1
Isoform Genbank
accession
number
Number 
of amino 
acids
Molecular
weight
(Da)
Isoelectric
point
Chromosome
location
Tissue
expression
hlCaP BAA04231 Cnn1 297 33,179 8.99 19p13 Smooth muscle
(basic)
h2CaP Q99439Cnn2 309 33,697 7.58 19p13 (2, 3, 6, Most non-muscle cells
(neutral) 11, 21)
h3CaP AAB35752 Cnn3 329 36,413 5.51 1p21 Neurons; glial cells
(acidic)
Chromosome location, basic physicochemical parameters, and tissue expression of the
three human CaP genes.
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mass and isoelectric points of the CaPs (Table 1), and they also serve as antigenic 
epitopes for isoform-specific antibodies. The hlCaP molecule is monomeric in 
solution, and by electron microscopy a variety of contours have been described, 
ranging from rod shaped to globular, suggesting that there are flexible regions in the 
molecule (Stafford et al., 1995). Unlike the highly ordered N-terminal portion, 
structural determination of the complete hlCaP molecule by X-ray crystallography 
has remained elusive.
In human, mouse and rat, the Cnnl gene (encoding hlCaP) comprises seven 
exons that covers 10.2,10.7, and 8.0 kilobases of genomic sequence, respectively and 
the human Cnnl gene was mapped to chromosome 19pl3 (Maguchi et al., 1995; 
Nobrega et al., 2000; Samaha et al., 1996). Fluorescent in situ hybridization has 
indicated that chromosome lp21 is the most likely site for the Cnn3 gene. The 
chromosomal location of Cnn2 is ambiguous. While several studies have mapped the 
Cnn2 gene to chromosome 19 (in close proximity to the Cnnl gene at p i3), others 
have identified chromosome 21 as its putative gene locus (Cheng et al., 1994; Masuda 
et al., 1996). Reports of additional assignments to chromosomes 2, 3, 6  and 11 have 
added to the confusion, and clarification of the exact locus by fluorescent in situ 
hybridization is required to resolve this issue.
1.6.2 Structure
The molecular domain structure of the CaPs as depicted in Figure 9 reveals 
their modular construction. The most prominent structural element is the N-terminal 
CH domain, a predominantly helical globular structure that gave name to a large 
superfamily of protein-protein interaction modules present in many actin filament 
crosslinkers and bundlers. The second modular component is the short tandem
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CH domain
NH
COOHCLIK repeats
ABS1 Intrinsically unstructured region 
 (actin binding)_______
Figure. 9. Schematic representation of the CaP molecule. All three CaPs share a
similar molecular domain organization. Following the hydrophilic Ca2+/CaM-binding 
peptide the highly structured N-terminus is dominated by the 100 residue long, 
globular CH domain, and an adjacent, surface-exposed region that contains the 
myosin ATPase inhibiting peptide, and actin-binding site 1 (ABS1). The tandem 
CLIK23 repeats constitute the major actin-binding site in CaPs. They remain unfolded 
in solution and appear to structurally reorganize upon contact with the actin filament. 
All putative phosphorylation sites (Serl75, 215, 254; Thrl70, 180, 184, 220, 224,
259; Tyrl82 and Tyr261) lie within this region. The C-terminal end contains the tail 
regions that are unique in length and composition in all three CaP isoforms.
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sequence repeats in the C-terminal half. Both the highly basic, 23-residue repeat 
sequences, and the acidic intervening sequences follow the consensus of a type I 
intrinsically unstructured protein, which may account for the flexible folding 
properties of the CaP molecules. Between the CH domain and the tandem repeats 
there is a region spanning amino-acidsl42-163 that forms an ABS, which mediates 
actin binding and that contains the myosin ATPase inhibitory peptide (residues 142- 
147) (el-Mezgueldi et al., 1996; Mezgueldi et al., 1992). The extreme C-termini of 
CaPs contain the isoform-specific tail sequences. The CH domains show high 
functional plasticity (Gimona et al., 2002). Documented interactions with CH 
domains range from actin, microtubules and intermediate filaments, to mitogen- 
activated protein kinases (MAPKs), Zn2+fingers, Ca2+-binding proteins of the S I00 
family, and phospholipids. The involvement of the CH domain of CaPs in actin 
binding, however, remains controversial. Although earlier cryoelectron microscopy 
analysis placed the hlCaP CH domain into the large groove of the actin filament, 
deletion studies have shown that the CH domain is neither sufficient nor necessary for 
thin filament binding, and that instead, the C-terminal tandem repeats mediate the 
CaP-actin association (Gimona and Mital, 1998; Hodgkinson et al., 1997). This view 
is supported by evidence for a CH domain-like mass at the putative CH domain 
location, using a recombinant hlCaP deletion construct that lacks the CH domain 
(Galkin et al., 2006). The calponin Hke (CLIK23) repeats are essential for the actin- 
binding function of the CaPs, and the strength of actin binding is directly correlated to 
the number of CLIK repeats. In vitro F-actin co-sedimentation assays using 
recombinant proteins, and over-expression studies in cultured cells have shown that 
the mode of binding and the binding interface are conserved in CaP-like molecules 
from worms to man. The binding of multiple CLIK2 3  repeats reduces actin filament
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turnover in living cells and strongly interferes with cytokinesis (Lener et al., 2004). 
Comprehensive deletion and domain swap experiments have revealed that the unique 
tail sequences of all three CaP isoforms negatively regulate their F-actin binding 
(Burgstaller et al., 2002).
The presence of one or multiple CLIK2 3  repeats identifies the members of the 
CaP family. All vertebrate CaPs are constructed following the principles depicted in 
Figure 9. Vertebrates also express CaP-related molecules of the smooth muscle 
protein 22 (SM22)/Transgelin (TGN) family, which contain single copies of the 
CLIK2 3  motif. The three genetic SM22/TGN variants (TGN 1, TGN2 and 
TGN3/NP25) exhibit similar basic modular arrangements, and cell-type-specific 
expression. Invertebrate orthologues of the CaP-related proteins are found in the 
tapeworm Echinococcus granulosus (myophilin) (Martin et al., 1995) and in 
Drosophila melanogaster (mp20) (Ayme-Southgate et al., 1989). The trematode 
parasites Schistosoma mansoni and japonicum express a unique CaP homologue that 
contains five complete CLIK2 3  modules (Yang et al., 1999). Nematodes, including the 
Caenorhabdites family, and the parasite Onchocerca volvulus lack close CaP 
homologues, although they contain an SM22/TGN homologue (incorrectly annotated 
as a CaP homologue, Cpn-1). Notably, UNC-87 (in C. elegans) and OV9M (in O. 
volvulus) each contain seven copies of the CLIK2 3  motif, but do not contain an N- 
teiminal CH domain (Goetinck and Waterston, 1994; Irvine et al., 1994). UNC-87 is a 
component of the worm muscle thin filaments and shows actin binding and bundling 
activity in vitro. Saccharomyces cerevisiae and Schizosaccharomyces pombe lack any 
of the multiple-CLIK2 3  repeat components. Scpl (S. cerevisiae) and SPAC4F8.10c (S. 
pombe) resemble single CLIK23-containing SM22/TGN, but functional data exist only 
for Scpl (Winder et al., 2003); Scpl binds and bundles actin filaments in-vitro.
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1.6.3 Biological functions
In vitro, all CaPs bind to both muscle and non-muscle actin, although it is 
currently not clear if in vivo the CaP isoforms have a preference for any of the six 
mammalian actin isoforms. At low CaP to actin ratios, CaP binds to F-actin via a 
globular motif that comprises its entire C-terminal region (including the ABS1, the 
tandem CLIK2 3  repeats, and the regulatory tail) (Galkin et al., 2006). Native hlCaP 
from chicken gizzard binds to immobilized G-actin with a similar affinity to F-actin 
(Kd, 0.15 mM) (Ferjani et al., 2006b). The hypothesis that G-actin regulates the 
activity status of CaP is intriguing, but it requires confirmation at the cellular level. 
The binding of CaP to F-actin is sensitive to CaP phosphorylation at several Ser, Thr 
and Tyr residues that are located in the C-terminal half of the molecule (Abouzaglou 
et al., 2004; Nakamura et al., 1993; Winder et al., 1993a; Winder and Walsh, 1990b). 
The binding of Ca2+/CaM to hlCaP (but not to h3CaP) inhibits the interaction with 
actin, and consequently releases the block on actin-activated myosin MgATPase 
activity (Abe et al., 1990; Applegate et al., 1994; Mezgueldi et al., 1992).
One Ca2 +/CaM-binding site (amino-acids 1-30) resides in the N-termini of the 
CaPs and a second site exists just before ABS1. Information on potential CaP 
interactions with microtubules and intermediate filaments (vimentin or desmin) has 
come from in-vitro biochemical studies and localization studies in smooth muscle by 
electron microscopy (Fujii et al., 1997; Fujii and Koizumi, 1999). Binding to the 
desmin tetramer subunit is stronger than to the polymerized filament, suggesting the 
possible involvement of CaP in the assembly mechanism of intermediate filaments 
(Fujii et al., 2000; Mabuchi et al., 1997; Wang and Gusev, 1996). Additional 
interactions with components of the cytoskeleton have been described for TM 
(Vancompemolle et al., 1990), myosin (Szymanski and Tao, 1993), CAD (Graceffa et
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al., 1996), smooth muscle archvillin (Gangopadhyay et al., 2004), the S I00 proteins 
(Wills et al., 1993), and gelsolin (Ferjani et al., 2006a). CaP also interacts with 
signalling components, including ERK1/2 (Menice et al., 1997), pl60ROCK (Kaneko 
et al., 2000), PKCa and PKCe (Leinweber et al., 2000). ROCK phosphorylates CaP at 
several sites (Thrl70, Serl75, Thrl80, Thrl84 and Thr259), which provides another 
regulatory mechanism for CaP, in addition to the phosphorylation by Ca2+/CaM 
kinase II (CaMKII), and PKCa. In addition, CaP also was found in a cGMP kinase 
signalling complex involved in the regulation of the Ca2+ -ATPase II (SERCA) 
activity together with the IP3 receptor I (IP3 RI), IP3 receptor associated cGMP kinase 
substrate (IRAG) and cGMP kinase lp  (Koller et al., 2003). Since most of these data 
have come from experiments with hlCaP, the general validity of these mechanisms 
towards all of the CaP isoforms awaits experimental verification.
In knock-out mice lacking hlCaP, SMC contraction and Ca2+'sensitivity is 
marginally affected, with the exception of an increase in unloaded shortening velocity 
of these cells, which indicates a negligible involvement of hlCaP in mediating Ca2+- 
dependent contractile signals (Matthew et al., 2000; Yoshimoto et al., 2000b).
Notably however, these animals have a significant reduction in actin and TM 
expression, indicating a relationship between the expression levels of hlCaP and 
transcription of the components of the actin machinery. Loss of hlCaP leads to 
enhanced ectopic bone formation in vivo, which is mediated by bone morphogenetic 
protein in hlCaP knock-out mice, suggesting that hlCaP negatively regulates the 
osteogenic programme (Yoshikawa et al., 1998).
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1.6.4 Differentiation and pathology
Growth factors regulate the expression levels of hlCaP in SMCs. Up- 
regulation of hi CaP, in response to transforming growth factor (TGF)-|31, is in line 
with a general differentiation-promoting activity (Ueki et al., 1998). Stimulation by 
tumor necrosis factor (TNF)-a and platelet-derived growth factor (PDGF)-BB almost 
completely abrogates hlCaP expression in cells cultured on glass surfaces, while 
aortic vascular SMCs cultured on polymerized collagen require both PDGF-BB and 
interleukin (IL)-1|3 to alter hlCaP expression (Chen et al., 2006; Dykes and Wright,
2007). It will be important to determine if expression of the other CaP isoforms is 
similarly sensitive to growth-factor-induced signalling, and how the composition and 
mechanical properties of the extracellular matrix modulate the conductivity for 
transcriptional regulation.
Together with less than a handful of components, the expression of hlCaP 
serves as a reliable marker for the differentiated contractile smooth muscle phenotype. 
Dedifferentiated SMCs that convert to the synthetic phenotype, and primary SMCs in 
culture rapidly down-regulate hlCaP expression. In response to activin-A-stimulated, 
and actin responsive element (ARE)-mediated transcriptional activation, pancreatic 
AR42J-B13 cells (which expresses all three CaP isoforms) down-regulate hlCaP 
expression and produce insulin, whereas over-expression of hlCaP suppresses 
activin-A-induced ARE activity and differentiation (Morioka et al., 2003). The CH 
domain is necessary for this suppression, and it was thus proposed that a specific 
function that resides in the CH domain of hlCaP (but not of h2CaP or h3CaP) 
regulates pancreatic cell differentiation and transcriptional activity. Over-expression 
of h3CaP in cultured rat hippocampal neurons increases the density and length of 
dendritic spines, indicating a regulation of neuronal cell plasticity by h3CaP (Ferhat et
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al., 2003). This effect requires the actin-binding domain of h3CaP, in agreement with 
an actin filament-stabilizing function of CaPs.
Expression of h2CaP regulates endothelial cell migration both in vitro and in 
vivo, and h2CaP is involved in guiding vascular development through its regulation of 
ERK signalling, by increasing ERK phosphorylation levels via MAPK (Tang et al., 
2006). Differential gene expression profiling of solid versus metastatic 
adenocarcinoma has revealed a molecular signature that comprises 17 genes 
(Ramaswamy et al., 2003). Down-regulation of hlCaP expression as part of this 
signature profile predicts, with high fidelity, the propensity of a solid tumour to form 
metastases. Independent studies on osteosarcoma (Yamamura et al., 1998) and 
fibrosarcoma (Takeoka et al., 2002) have confirmed the importance of hlCaP 
expression in the suppression of tumorigenesis and metastasis . Subsequent 
investigations in vitro in metastasizing adenocarcinoma and melanoma cell lines have 
revealed that elevated expression levels of hlCaP indeed reduce cell motility and the 
formation of invasive podosome adhesions (Gimona et al., 2003). The actin-binding
I'XCLIK repeats are the necessary and sufficient modules for mediating this activity 
(Lener et al., 2004). In further support of a tumour suppressing function, the loss of 
hlCaP prevents neovascularization of tumours and regulates the maturation of blood 
vessels, also in the tumour-host microenvironment (Yamamura et al., 2007). Ectopic 
expression of hlCaP reduces tumour size, DNA synthesis, mitotic activity, cell 
motility, and suppresses proliferation and tumorigenesis in human leiomyosarcoma.
As a bona fide tumour suppressor, hlCaP has thus considerable potential for gene- 
therapy (Takahashi and Yamamura, 2003). In addition, hlCaP could be related to 
many other human diseases where the etiologies are still unknown. The chromosome 
region 19pl3.2 where hlCaP resides has been associated with tumour progression
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(Koga et al., 2002a; Koga et al., 2002b; Pezzolo et al., 2008; Prazeres et al., 2007; 
Stankov et al., 2004; Yang et al., 2004), with systemic lupus erythematosus (Namjou 
et al., 2002), Alzheimer disease (Wijsman et al., 2004), hearing impairment (Santos et 
al., 2006) and polycystic ovary syndrome (Urbanek et al., 2005).
1.7 CH domains
The ABD of many actin crosslinkers consists of two CH domains in tandem. 
CH domains are ~100 amino acids long and with the refinement of algorithms for the 
identification of sequence motifs, more CH domain-containing proteins were 
identified. Currently, CH domains have been identified in tandem in ABPs and as 
single domain in many ABPs and signalling proteins (Stradal et al., 1998). Six CH 
domain subtypes are distinguished according to their sequence similarities. Type 1 
and type 2 CH domains are generally found in tandem and form an ABD, although 
type 2 CH domains have been also found as a single domain (e.g. smoothelin). Type 3 
CH domains are present in ABPs (e.g. calponin and SM22a) and signalling proteins 
(e.g. Vav, IQGAP and ARHGEF6 ). Types 4 and 5 CH domains have been found in 
tandem in the focal adhesion-associated protein parvin. Both CH domains are 
phylogenetically closer to the type 1 CH domain. Type 6  CH domains are found in the 
end-binding (EB) protein family and are thought to mediate microtubule binding 
(Gimona et al., 2002).
The overall secondary and tertiary structures of the CH domains seems to be 
conserved, although CH domain subtypes show low sequence similarities, which 
could allow functional diversity among the CH domains. The ABDs are able to bind 
actin filaments but only the type 1 CH domains have the ability to interact with 
filaments, while the type 2 CH domains do not (Way et al., 1992). Yet, they
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contribute to the actin-binding affinity of the whole ABD (Lorenzi and Gimona,
2008).
1.7.1 Type 3 CH domains
Type 3 CH domains are found as a single module in cytoskeletal and 
signalling proteins such as CaP, SM22a or TGN, the protoncogene Vav (Katzav et 
al., 1989), IQ motif containing GTPase activating protein (IQGAP) and Rho guanine 
nucleotide exchange factor 6  (ARHGEF6 ). Type 3 CH domains lack actin-binding 
activity and their biological function in many proteins remains elusive. It was shown 
for Vav that the CH domain regulates its GEF activity (Aghazadeh et al., 2000; 
Zugaza et al., 2002). Vav is a 98-kDa protein that regulates the GTPase activity of the 
Rho family GTPases facilitating the exchange of GDP for GTP (Olson et al., 1996). 
Vav activation is regulated by tyrosine phosphorylation (Crespo et al., 1997) and it is 
thought that a deletion in the CH domain is the cause for its transforming activity 
(Katzav et al., 1991) mediated by a phosphorylation-independent GEF activity. The 
exchange activity of Vav is autoinhibited by the intramolecular binding of the acidic 
region (Ac) and the Dbl homology (DH) domain where the GEF activity resides. This 
interaction is interrupted upon tyrosine phosphorylation of the protein and Vav 
becomes active (Aghazadeh et al., 2000). However, the deletion in oncogenic Vav 
seems to impair the contact between the Ac region and the DH domain (Hornstein et 
al., 2004).
IQGAP is a protein of 189-kDa, which carries an N-terminal type 3 CH 
domain and binds actin filaments directly (Bashour et al., 1997), but the actin-binding 
site has not yet been defined precisely. IQGAP also possesses several IQ domains that 
bind to CaM (Hart et al., 1996) and a Ras GTPase-activating protein (GAP)-related
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domain; however it does not show GAP activity. IQGAP is able to integrate signalling 
pathways with the actin cytoskeleton, since actin-regulatory proteins such as Cdc42 
and Racl interact directly with IQGAP (Kuroda et al., 1996).
ARHGEF6  or aPIX is a 61-kDa protein and like Yav it also possesses GEF 
activity. Interestingly the N-terminal CH domain of ARHGEF6  seems to be 
functionally similar to the CH domain of Vav, and thus ARHGEF6  lacking the CH 
domain shows constitutive GEF activity (Daniels et al., 1999). In addition, mutations 
on the CH domain have been associated to X-linked forms of mental retardation 
(Kutsche et al., 2000).
SM22a, which resembles a shorter version of CaP carries an N-terminal CH 
domain followed by a single CLIK2 3  repeat, which contains the actin-binding activity 
of the protein (Gimona and Mital, 1998). Recently it was shown that SM22a is able to 
regulate the expression of the 92-kDa gelatinase (MMP-9) protein, which is involved 
in matrix degradation and cancer cell invasion. Even more, it was demonstrated that 
the presence of the CH domain is required for MMP-9 downregulation (Nair et al., 
2006).
The type 3 CH domains of calponins have been shown to be important for the 
differentiation of pancreatic acinar cells into insulin producing cells (Morioka et al., 
2003) and have been shown to interact with ERK and PKC (Leinweber et al., 2000; 
Leinweber et al., 1999). However, the physiological roles of these interactions remain 
elusive.
1.8 Cell division
Contractile networks of actin filaments are fundamental for cell division. In 
combination with ABPs (e.g. cortexillin, fimbrin and myosin), actin filaments tune the
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mechanical properties of the actin cytoskeleton to constrict the mother cell into two 
daughter cells. The life-cycle of cells are separated into four major phases known as 
G l, S, G2 and mitosis (M phase). During G l, S and G2 cells prepare all of the 
molecular machinery necessary to go through M phase including DNA duplication (S 
phase) (Lodish et al., 2003).
The life-cycle of cells and the molecular processes involved during the many 
phases of cell division differ among organisms. Eukaryotic cell division is different 
from prokaryotic cell duplication, and within the eukaryotic world differences are 
found between plants and animals. The major differences between plant and animal 
cell division are found in the cytokinesis process during the last phase of mitosis, 
which is responsible for partitioning the cell components into the two daughter cells. 
The process of mitosis can be divided into several stages known as prophase, pro­
metaphase, metaphase, anaphase and telophase. Chromosomes are condensed into 
chromatids during the prophase. Prometaphase is characterized by the break down of 
the nuclear envelope and the formation of microtubule-based structure known as the 
mitotic spindle apparatus. During metaphase chromosomes are positioned on the 
spindle equator of cells with the help of the spindle microtubules. Anaphase is 
characterized by the beginning of cytokinesis and the movement of chromosomes to 
opposite poles of cells (Lodish et al., 2003).
Cytokinesis is driven by a specialized structure known as the contractile ring, 
which is close to the plasma membrane that creates a cleavage furrow that divides the 
two daughter cells. The major steps of cytokinesis are cleavage furrow formation at 
cell periphery, furrow ingression, midbody formation and cell separation. During 
cleavage furrow ingression the central microtubules get compressed and form a 
compact structure known as the midbody. This structure is not yet understood in
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detail. The last step of cytokinesis is cell separation, and this occurs by abscission, 
which was recently described to be a process that requires lipid transport that allows 
the physical separation of the daughter cells (Matheson et al., 2005).
1.8.1 Role of actin-binding proteins during cytokinesis
The contractile ring is an actomyosin-based structure (Fujiwara et al., 1978; 
Schroeder, 1973), which generates the required forces to promote furrow ingression 
(Mabuchi and Okuno, 1977; Yamakita et al., 1994). As a general view, myosin II 
pulls actin filaments that are either crosslinked to other actin filaments or to the 
plasma membrane constricting the cleavage furrow cortex (Reichl et al., 2008). 
Myosin II is crucial for cytokinesis progression and phosphorylation is necessary for 
its activation and for force generation (Satterwhite et al., 1992; Yamakita et al., 1994). 
During cytokinesis, myosin II can be regulated by Rho family GTPases (Matsumura, 
2005). It is known that RhoA activates ROCK, which in turn phosphorylates MLC, 
thus participating in the activation of myosin II. On the other hand, myosin II can be 
activated by myosin light chain kinase (MLCK), but it is not known what activates 
MLCK during cytokinesis (Matsumura, 2005). Strikingly, it is not yet fully 
understood how myosin and actin-crosslinkers interact to control the dynamics of 
furrow ingression. It is thought that actin-crosslinking proteins are necessary at the 
contractile ring to arrange the cortical actin filaments in a manner such that myosin 
can pull and exert tension on the plasma membrane. Overexpression of a-actinin 
leads to aberrant cytokinesis due to inhibition of actin filament turnover (Mukhina et 
al., 2007), while depletion of a-actinin induces accelerated cytokinesis. The actin 
filament-crosslinker cortexillin has also been found to be necessary for cytokinesis 
progression. Depletion of cortexillin leads to the formation of giant binucleated cells
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(Faix et al., 1996). Currently, cortexillin is one of the few actin-crosslinking proteins 
that have a direct role in cytokinesis. Depletion of most of the actin crosslinkers does 
not lead to significant defects in cell division (Wu et al., 2001); on the other hand, 
their overexpression does. The fact that depletion of actin crosslinkers does not affect 
cell division might be explained by the overlapping functions of actin-crosslinking 
proteins.
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Aim of the study
The actin-binding activity of hlCaP has been extensively studied in vitro and it has 
been demonstrated that its affinity for actin filaments is reduced by Ca2+/CaM, 
phosphorylation and its C-terminal tail. However, little is known about its regulation 
in live cells, and whether these regulatory mechanisms occur in vivo remains 
unknown. The aim of this study was to describe and understand the regulatory 
mechanism that controls hlCaP actin-binding function in live cells, and to investigate 
the role of hlCaP during cell division.
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CHAPTER 2: MATERIAL AND METHODS
2.1 Reagents and antibodies
Mouse monoclonal antibody against Myc tag was purchased from Santa Cruz 
(Santa Cruz, CA) and against His tag from QIAGEN (Milano, Italy). Rabbit 
polyclonal antibody against GST was a gift from Dr. Antonella DeMatteis (Consorzio 
Mario Negri Sud). Horseradish peroxidase conjugated goat antibody against mouse 
antibody was purchased from Amersham (Milano, Italy). Mouse monoclonal antibody 
against basic calponin was purchased from Dako (Milano, Italy). Phalloidin labelled 
with Alexa 568 was from Molecular Probes (Milano, Italy). HiTrap chelating HP and 
glutathione sepharose 4 fast flow from Amersham (Milano, Italy) were used to purify 
His and GST tagged proteins, respectively. All other reagents used in this study were 
either obtained as specified elsewhere, or were obtained at the highest possible 
purities from Sigma Aldrich and Calbiochem.
2.2 Cell culture, transfection and fluorescence microscopy
A7r5 rat vascular smooth muscle cell line (ATTC) were grown in low glucose 
Dulbecco’s Modified Eagle’s Medium (Invitrogen, Milano, Italy) supplemented with 
10% foetal bovine serum (PAA, Linz, Austria), penicillin/streptomycin/glutamine 
(Invitrogen, Milano, Italy) at 37 °C and 5% CO2 . For transient transfections, cells 
were grown in 60 mm plastic culture dishes and transfected with Superfect (QIAGEN, 
Milano, Italy) at 70% confluence, essentially as described elsewhere (Kranewitter et 
al., 2001). Cells were replated onto 15 mm cover slips 16 h post-transfection and 
prepared for fluorescence microscopy. For staining, cells were washed three times in 
phosphate-buffered saline (PBS) (138 mM NaCl, 26 mM KC1, 84 mM Na2 HP0 4 , 14
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mM KH2 PO4 , pH 7.4), fixed in 3.7% paraformaldehyde (PFA; Merck) in PBS for 30 
min and permeabilized in 3.7% PFA / 0.3% Triton X-100 in PBS for 1 min. 
Fluorescence images were recorded on a Zeiss Axioscope equipped with an Axiocam 
driven by the manufacture’s software package equipped with a 63x, 1.4NA Plan- 
APOCHROMAT objective (Zeiss). Live images of transiently transfected A7r5 cells 
with GFP constructs were recorded on a Nikon Eclipse TE2000 equipped with a 60x 
Plan Apo VC 1.40NA oo/0.17 WD 0.13 objective (Nikon).
2.3 Vectors and constructs
Figure 10 shows a schematic representation of the constructs used in this study 
and Table 2 lists the oligonucleotide sequences of the primers used to generate the 
constructs. Dr. Mario Gimona (Consorzio Mario Negri Sud) has kindly provided the 
pEGFP mammalian expression vectors harbouring the cDNAs of the mouse basic, 
neutral and acidic calponin, and a tail-deleted form of basic calponin. The pEGFP 
mammalian expression vectors harbouring the cDNAs of the mouse basic calponin 
and the tail deleted form (Danninger and Gimona, 2000) were used as templates and 
amplified by PCR (using PFU Turbo, Stratagen) with the primer pairs 0001/0055 and 
0001/0068, respectively, and subcloned into the BspEI/EcoRI-digested pEGFP-Cl 
(BD Biosciences/Clontech) expression vectors. pEGFP-Cl harbouring the sequence 
of basic calponin was further used as template for the generation of hlCaP lacking 
CH domain (hlCaPACHD) using the primer pairs 00135/0006 and sublcloned into 
BspEI/BamHI-digested pEGFP-Cl expression vector. pEGFP-Cl harbouring the 
sequence of the tail-deleted form of basic calponin was used as template for the 
generation of hlCaP lacking the CH domain and the C-terminal tail (hi CaP ACHD AT) 
using the primer pairs 0135/0068 and sublcloned into BspEI/EcoRI-digested pEGFP-
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Cl vector. The cDNA of hi CaP in pEGFP-Cl was also used as a template for the 
amplification of the CLIK2 3  repeats with (CLIK) and without the C-terminal tail 
(CLIKAT) using the primer pairs 0050/0055 and 0050/0068, respectively, and both 
have been subcloned into BspEI/EcoRI-digested pEGFP-Cl expression vectors. 
pEGFP carrying the genes for basic calponin with a S I75A (hlCaP-S175A) and 
S175D (hlCaP-S175D) mutations was obtained from Dr. Gimona. These constructs 
were used as templates for the amplification of both mutant calponins using the 
primer pairs 0001/0055 and subcloned into BspEI/EcoRI-digested pEGFP-Cl. 
pEGFP-Cl vectors harbouring the sequences for hlCaP-S175A and hlCaP-S175D 
were used as templates for the generation of an additional point mutation at Ser254 by 
site directed mutagenesis (Quickchange, Stratagene) using the primer pairs 0062/0063 
for the generation of S254A (hlCaP-S175/254A) and 0064/0065 for the generation of 
S254D (hlCaP-S175/254D). The products of the site directed mutagenesis have been 
subcloned into a new BspEI/EcoRI-digested pEGFP-Cl expression vector.
The hlCaP mutant lacking the helix A and loop 1 (hlCaPAHxAALl) was 
generated in the following way: the pEGFP-Cl vector harbouring the cDNA of basic 
calponin was used as template for the amplification of two fragments; one 
corresponding to the nucleotide positions 1 to 142 (Frgl) and a second fragment 
(Frg2) corresponding to the nucleotides 169 to 894 using the primer pairs 0001/0117 
and 0121/0006, respectively. Frgl and 2 were digested with the endonuclease 
restriction enzymes BspEI/PvuII and Dral/BamHI, respectively. The two fragments 
were then subcloned into BspEI/BamHI-digested pEGFP-Cl expression vector.
pEGFP-Cl harbouring the cDNA of basic calponin was used as a template and 
amplified by PCR with the primer pairs 0083/0084 and subcloned into the 
EcoRI/XhoI- digested pCMV-Myc mammalian expression vector (Clontech).
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The Myc tagged hlCaP mutant lacking the helix A and loop 1 
(hlCaPAHxAALl) was generated in the following way: pCMV-Myc vector 
harbouring the cDNA of basic calponin was used as template for the amplification of 
two fragments; one corresponding to nucleotides 1 to 142 (Frgl) and a second 
fragment (Frg2) corresponding to the nucleotides 169-894 using the primer pairs 
0083/0117 and 0121/0084, respectively. Frgl and 2 were digested with the 
endonuclease restriction enzymes EcoRI/PvuII and Dral/Xhol, respectively. The two 
fragments were then subcloned into EcoRI/XhoI-digested pCMV-Myc expression 
vector.
The pEGFP vector harbouring the cDNA of basic calponin (Danninger and 
Gimona, 2000) was used as a template and the nucleotide sequence encoding for the 
CH domain was amplified by PCR with the primer pairs 0042/0043 and 0024/0044 
and subcloned into the Ndel/XhoI-digested pET-22b (Novagen) and XhoI/BamHI- 
digested pGEX-4T2 (Amersham) bacterial expression vectors, respectively.
The C-terminal tail of hlCaP fused to GST and Myc (GST-tail-myc) was 
generated in the following way: The pEGFP-Cl vector carrying the cDNA of basic 
calponin was used as a template and the nucleotide sequence encoding for the C- 
terminal tail was amplified by PCR with the primer pairs 0071/0072 and subcloned 
into EcoRI/BamHI-digested pTRChis2b (Invitrogen) bacterial expression vector. The 
pTRChis2b vector harbouring the nucleotide sequence of the tail with a Myc tag was 
amplified by PCR and subcloned into BamHI/Sall-digested pGEX-4T2 bacterial 
expression vector.
pEGFP mammalian expression vectors harbouring the cDNA of the mouse 
SM22a and the human Vavl was provided by Dr. Gimona. The recombinant hlCaP 
carrying the CH domain of SM22a (hlCaP-SMCH) or Vavl (hlCaP-VavCH) was
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generated in the following way: pEGFP-Cl vector harbouring the cDNA of basic 
calponin was used as template for the amplification of two fragments; one 
corresponding to the nucelotides 1 to 78 (FI) and a second fragment (F2) 
corresponding to the nucleotides 403-894 using the primer pairs 0001/0045 and 
0048/0006, respectively. pEGFP carrying the cDNA of SM22a was used as a 
template for the amplification by PCR of a third fragment (F3) corresponding the 
nucleotide sequence encoding for the CH domain of SM22a using the primer pairs 
0003/0004. Frg2 and 3 were first 5 ’-phosphorylated with T4 polynucleotide kinase 
(Invitrogen) and then digested with the endonuclease restriction enzymes BamHl and 
SacI, respectively. The two fragments were then subcloned into SacI/BamHI-digested 
pEGFP-Cl expression vector. Then F3 was digested with the restriction enzymes 
BspEI/SacI and subcloned into BspEI/SacI-digested pEGFP-Cl vector harbouring the 
sequences of F2 and F3. The recombinant hlCaP-VavCH was generated in a similar 
manner with the following differences: F2 was generated with the primer pairs 
0049/0006 and F3 was amplified by PCR from pEGFP carrying the cDNA of Vavl 
using the primer pairs 0034/0032.
The recombinant hlCaP with and without the tail fused to a N-terminal citrine 
and a C-terminal CFP (Y-hlCaP-C and Y-hlCaPAT-C) were generated in the 
following way: The pEGFP-Cl vector carrying the cDNA of basic calponin was used 
as a template and the nucleotide sequence encoding for the full-length protein or a 
tail-deleted form was amplified by PCR using the primer pairs 0100/0099 and 
0095/0096, respectively. Dr. Klaus M. Hahn (California, USA) kindly provided a 
RhoA biosensor, which was used as a template to amplify by PCR the nucleotide 
sequence coding for the citrine with the primer pairs 0093/0094. Then the PCR 
products of full-length calponin and the tail-deleted form were digested with the
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endonuclease restriction enzymes XhoI/EcoRI, and the citrine nucleotide sequence 
with EcoRI/BamHI. The citrine was then subcloned either with the full-length 
calponin or with the tail-deleted form into a XhoI/BamHI-digested pCDNA4a 
(Invitrogen) mammalian expression vector. The pECFP (BD Biosciences/Clontech) 
mammalian expression vector was used as a template and the nucleotide sequence 
coding for the CFP was amplified by PCR with the primer pairs 0093/0094. The PCR 
product was digested with the restriction enzymes Xhol/Apal and subcloned into 
XhoI/Apal-digested pCDNA4a vectors harbouring the nucleotide sequence coding for 
the full-length calponin or the tail-deleted form fused to a citrine.
CODE SEQUENCE 5 '  ->  3 '
0 0 0 1 GCTTCCG G AA TG TCTTCTG CA CATTTTAA C
0 0 0 3 GACGAGGAGCTCGAGGAGCG
0 0 0 4 TTTGGTCACAGCCAAACTGCC
0 0 0 6 CCAGGATCCCTAGGCAGAGTTGTAGTAGTTGTGC
0 0 2 4 CCCGGGATCCGACCATCAGCGGGAGCAGG
0 0 3 2 CTGGGCGATCGGGGTCCAGG
0 0 3 4 GGAATTCGAGCTCTGGCGCCAATGCACCC
0 0 4 2 GGAATTCCATATGGACCATCAGCGGGAGCAGG
0 0 4 3 GAGTGACGCTCGAGTTTGTCTTGGCCATGCTGGCC
0 0 4 4 GCTG ATGCCTCGAGTCATTTGTCTTGGCCATGCTGGCC
0 0 4 5 CTTAA G GGAGCTCCTCGTCGTATTTCTGGGC
0 0 4 8 GGAAACAAAGTCAATGTGGGAGTC
0 0 4 9 GGAAACAAAGTCAATGTGGGAGTCAAG
0 0 5 0 GGCAGGTCCGGAATTGGACTGCAGATGGGCAC
0 0 5 5 GCGAATTCTAGGCAGAGTTGTAGTAGTTGTGCGG
0 0 6 2 GGGGCCGCACAGAGGGGCATGACAGTGTATGGGCTTCC
0 0 6 3 GGAAGCCCATACACTGTCATGCCCCTCTGTGCGGCCCC
0 0 6 4 GGGGCCGACCAGAGGGGCATGACAGTGTATGGGCTTCC
0 0 6 5 GGAAGCCCATACACTGTCATGCCCCTCTGGTCGGCCCC
0 0 6 8 CGGAATTCCTATGCGCAGTACTTGGGATCGTACACC
0 0 7 1 GCGGATCCGCTGAACCCGGAGTACCCAGAG
0 0 7 2 CGAATTCTGGCAGAGTTGTAGTAGTTGTG
0 0 7 8 GGATCCCTGAACCCGGAGTACCCAGAG
0 0 8 3 G GA A TTCGGATGTCTTCTGCACATTTTAACC
0 0 8 4 CCGCGATCCTCGAGCTAGGCAGAGTTGTAGTAGTTGTGC
0 0 8 4 CCGCGATCCTCGAGCTAGGCAGAGTTGTAGTAGTTGTGC
0 0 9 3 CGGGATCCATGGTGAGCAAGGGCGAGGAG
0 0 9 4 G TCCGAATTCTCCGGACTTGTACAGCTCGTCCATGC
0 0 9 5 CA GCG A ATTCA TG TCTTCTG CACA TTTTA A CCG
0 0 9 6 CGAGTTCGCTCGAGGGCAGAGTTGTAGTAGTTGT
0 0 9 9 GTCGACGGGCCCCTACTTGTACAGCTCGTCCATGCC
0 1 0 0 GGAGTTCGCTCGAGTCCGGAATGGTGAGCAAGGGCGAGGAGCTG
0 1 1 7 CGGCGGCAGCTGGGCCAGCTTGTTCTTTACTTCAGC
0 1 2 1 CCCCG GTTTA AATACGGGATCATTCTTTGCG
0 1 3 5 GCCAAGTCCGGAGGAAACAAAGTCAATGTGG
Table 2. List of primers to generate the constructs used in this study. The code is an 
internal number used in the laboratory to track the sequences.
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Figure 10. CaP constructs used in this study. The main characteristic domains of the 
CaPs were kept aligned to facilitate the reading.
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2.4 Computational docking
The nucleotide sequence of Mus musculus hlCaP C-terminal tail was obtained 
from the data-bank in the National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.govf). The crystal structure of the rabbit muscle creatine 
kinase (PDB code, 2CRK) was downloaded from Protein Data Bank. The alignment 
between the C-terminal tail of hlCaP and the creatine kinase was obtained using the 
web-server NCBI blastp (http://blast.ncbi.nlm.nih.gov/). The computational docking 
models were generated with the FTDOCK algorithm, which permits an exhaustive 
search of translational and rotational space (Gabb et. al. 1997). The modelling of the 
tail 3D structure was determined by a segmented approach where the C-terminal tail 
of hlCaP was isolated and modelled with an individual template. A 33% 
homologueous sequence of the rabbit creatine kinase (EYPDLSKHNNH) was used as 
a template for the tail (LNPEYPELSEPTHNHHPHNYYNSA). Swiss PDB viewer 
was used to model the tail. The quality of the model was evaluated using the 
HOPPscore application (Sims and Kim, 2006) and with Ramachandran plot from 
VMD molecular graphic programme (Humphrey et al., 1996). Negative FTDOCK 
scores indicate overlap/interpenetration of the ligand and receptor and are therefore 
not possible. A score of zero indicates that the ligand and receptor do not interact at 
all, and large positive scores denote complex formation with good surface 
complementarity. The addition of the molecular surface volumes were performed in 
AutoDockTools 1.5.1 (Sanner, 1999). The surface electrostatic potentials, the 
solvation energy and the binding energy were assigned and analyzed with the adaptive 
Poisson-Boltzman solver (ABPS), which is included in AutoDockTools as a 
subroutine (Baker et al., 2001).
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2.5 Protein purification
The recombinant CH domain of hlCaP spanning the residues D27 to K 134 
was generated with the glutathione-S-transferase (GST) or 6xHis fusion protein 
system. The C-terminal tail of hlCaP spanning the residues L271 to A297 was 
generated with a C-terminal GST tag and an N-terminal myc tag. The bacteria strain 
BL21(DE3) was transformed with the expression vectors encoding for the 
recombinant proteins and grown to an optical density at 600 nm (OD600) of 0.4-0.6 at 
37 °C. Expression of the protein was induced with the addition of isopropyl thio-|3-D- 
galactoside (IPTG, Calbiochem) and incubating the cells for 4 h at 30 °C. 
Subsequently, cells were harvested by centrifugation at 6000x g and stored at -80 °C 
overnight. The cells with GST fused proteins were resuspended in 20 mM Tris, 5 mM 
EDTA and 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma), and lysed 
mechanically with a sonicator (Vibra Cell, SONICS). The lysates were centrifuged at 
15,000x g for 15 min, and the pellet containing the cell debris was discarded. The 
supernatant was mixed with glutathatione sepharose beads (Amersham) for 3 h at 4 
°C on a rotating support. Beads were packed into a 10 ml chromatography column 
(Bio-Rad) to purify the recombinant GST fused proteins. The beads were washed 
twice with 10 ml of PBS (pH 7.4) and eluted with 50 mM Tris (pH 8), 10 mM 
reduced glutathione and 1 mM PMSF. The eluates were dialysed against 20 mM Tris 
and 5 mM EDTA. Protein concentration was determined by the Bradford method 
using Bio-Rad protein-assay reagent. The purity of the eluted proteins was analyzed 
by SDS-PAGE and staining the gels with Coomassie blue.
Cells with His fused proteins were resuspended in 20 mM NaHP04 (pH 7.4), 
0.5 M NaCl and 1 mM PMSF, and mechanically lysed with a sonicator. The lysates 
were centrifuged at 15,000x g for 15 min, and the pellets containing the cell debris
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were discarded. The supernatant was applied to 1 ml Ni-conjugated-hiTrap Chelating 
HP column (Amersham) following the manufacturer protocol. The column was 
washed with 5 volumes of 0.02M NaHP04, 1M NaCl and lOmM imidazole (pH 7.2) 
and proteins were eluted with 0.02 M NaHP04, 0.5 M NaCl and a 0.05 to 0.5 M 
imidazole gradient (pH 7.4). The fraction containing the His fused proteins was 
determined by measuring the absorbance of the eluates at OD^q. The eluates 
containing the His fusion proteins were dialysed against 20 mM Tris and 5 mM 
EDTA. Protein concentration was determined by Bradford method using Bio-Rad 
protein-assay reagent. The purity of the proteins was analyzed by SDS-PAGE and 
staining the gels with Coomassie blue.
2.6 Overlay assay
Pure GST-tail-myc, GST-CHD or CHD-His were spotted onto a nitrocellulose 
membrane. The blots were blocked with 20 mM Tris, 136 mM NaCl, 0.05% Tween20 
(TBS-T) with 5% milk for 1 h at room temperature. Blots with immobilized GST- 
CHD or CHD-His were incubated with TBS-T containing lOpg of GST-tail-myc for 2 
h at room temperature whilst blots with immobilized GST-tail-myc were incubated 
for the same period of time with TBS-T containing lOpg of GST-CHD or CHD-His. 
After incubation the blots were rinsed once with TBS-T and PBS was immediately 
added with 4% PFA for 1 min. Then blots were washed three times with TBS-T and 
proceeded with the detection with the corresponding antibodies, as for Western 
blotting.
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2.7 Fluorescence resonance energy transfer (FRET)
FRET assays were performed with transiently transfected A7r5 cells plated in 
a 30 mm glass-bottomed dishes (Matek) for live-cell imaging. Before imaging, 25 
mM HEPES was added to the media. Images were recorded at 37 °C on a Zeiss 
LSM510 META confocal microscope equipped with a 63x, 1.4NA Plan- 
APOCHROMAT objective (Zeiss). CFP was excited with a 458nm Ar-ion laser. 
Emissions of Y-hlCaP-C and Y-hlCaPAT-C were collected with the Meta detector to 
analyze the spectral emission of each construct. FRET was measured using the donor 
dequenching technique (Bastiaens and Jovin, 1996), in which the fluorescence of the 
CFP is monitored after bleaching the acceptor (YFP). Two images were recorded 
before bleaching and a third image immediately after bleaching the YFP in a region of 
interest (ROI) within the cell. The outer region of the ROI was used as a control. The 
values of the fluorescence intensities were recorded before (IbB) and after bleaching 
(IaB) in the ROI and outside the ROI. The differences between IaB -  IbB were 
considered as the variations in the fluorescence intensities of the CFP. The variation 
of the fluorescence outside the ROI before and after bleaching was relatively low; 
therefore, it was not necessary to apply a correction due to laser power fluctuations or 
for the exposure of the cell to the light of the laser during bleaching. A student’s T- 
test was applied to analyze if the variations between the samples are significant.
2.8 Fluorescence recovery after photobleaching (FRAP)
FRAP was performed in transiently transfected A7r5 cells with GFP fused 
hlCaP, hlCaP AT, hlCaPACHD and hlCaP ACHDAT. The cells were plated in a 30 
mm glass-bottomed dishes and monitored at 37 °C on a Zeiss LSM510 META 
confocal microscope equipped with a 63x, 1.4NA Plan-APOCHROMAT objective
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(Zeiss). Two images were recorded before bleaching, a third image immediately after 
bleaching a region of interest (ROI) within the cell containing stress fibres, and a 
fourth image 2 or 5 minutes after bleaching. The outer region of the ROI (OROI) was 
used as a control. The values of the fluorescence intensities were recorded in the ROI 
and OROI before (IbB) and after 2 or 5 minutes of bleaching (IaB). Variation in the 
fluorescence of GFP in the non-bleached area can occur due to laser-power 
fluctuations, natural bleaching of the fluorophores or loss of the focal plane during the 
recording time. Hence, the ratio between IbBoRoi/IaBoRoi in the OROI was used as 
the correction value for the IaB of the ROI (IaBCOrr):
IaBCorr= (IbBoRoi/IaBoRoi)*IaBRoi 
The IaBCorr was then used to obtain the percentage of fluorescence recovery, 
considering IbBROi as 100% of fluorescence.
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CHAPTER 3: RESULTS I
HlCaP has been demonstrated to be an ABP that stabilizes actin filaments and 
regulates smooth muscle contraction. However it is still unclear how the actin-binding 
activity of hlCaP is regulated and no regulatory mechanism has been described in 
detail. One of the first regulatory mechanisms to be proposed was the binding of 
Ca2+/CaM (Abe et al., 1990; Mezgueldi et al., 1992) to hlCaP, which inhibits the 
interaction with actin and the hiCaP-mediated inhibition of the MgATPase activity of 
myosin II. Nevertheless, in-vivo experiments are needed to corroborate if such 
mechanism occurs in cells. Another regulatory mechanism could be mediated by 
hlCaP phosphorylation. It has been shown that PKC and ERK1/2 bind hlCaP, but the 
biological significance of these interactions remains elusive. Phosphorylation of 
hlCaP significantly reduces its actin-binding activity and suppresses its ability to 
inhibit the actin-activated ATPase activity of myosin. It has been shown that hlCaP 
can be phosphorylated in vitro by PKC , Ca2+/CaM-dependent protein kinase II 
(Ca2+/CaMKII), ROCK (Kaneko et al., 2000; Winder and Walsh, 1990a; Winder and 
Walsh, 1990b) and Fyn (Abouzaglou et al., 2004). The main phosphorylated sites 
produced by PKC, Ca2+/CaMKII and ROCK include Serl75 and Ser254, while Fyn 
phosphorylates mainly Tyrl82 and Tyr261. However it is still unknown whether 
phosphorylation of hlCaP occurs in vivo or not. While some laboratories have 
detected phosphorylated hlCaP upon muscle contraction after incubation with radio 
labelled isotopes (Carmichael et al., 1994; Gerthoffer and Pohl, 1994; Mino et al., 
1995; Winder et al., 1993a), other groups have failed to do so (Adam et al., 1995; 
Barany and Barany, 1993; Barany et al., 1991; Gimona et al., 1992). In any case, 
phosphorylation of Serl75 of hlCaP is sufficient to inhibit its interaction with actin in
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vitro (Tang et al., 1996; Uyama et al., 1996), but in vivo evidence for regulation by 
Ser/Thr phosphorylation is missing.
3.1 Phosphorylation may not regulate the actin-binding activity of hlCaP
GFP tagged hlCaP decorates and colocalizes with actin filaments. Therefore, 
to understand whether phosphoiylation regulates the actin-binding activity of hlCaP 
in live cells, I have compared the effects on actin colocalization of hlCaP site-specific 
mutants in which Serl75 was replaced by alanine (hlCaP-Serl75A) or aspartate 
(hlCaP-Serl75D). To analyze the effects of both Serl75 and Ser254,1 also compared 
the effects of a double mutant in which Serl75 and Ser254 had been replaced for 
either alanine (hlCaP-Serl75/254A) or aspartate (hlCaP-Serl75/254D). The reason 
for exchanging the serine for an aspartate was to mimic the phosphorylated form of 
hlCaP while the presence of an alanine renders the residue non-phosphorylatable. The 
constructs were transfected into A7r5 rat smooth muscle cells, which contain a high 
density of actin filaments that allows the study of actin-binding proteins and, also 
express endogenous hlCaP. Figure 11 shows that hlCaP-S175A and hlCaP-S175D 
colocalize with actin filaments similar to wild-type hlCaP (Fig. 11 A, B and C). This 
suggests that phosphorylation of Serl75 does not affect the actin-binding activity of 
hlCaP in resting interphase cells. This result goes contrary to earlier results, where it 
was shown that the exchange of Serl75 for an alanine or aspartate is sufficient to 
inhibit hlCaP actin binding in vitro (Tang et al., 1996; Uyama et al., 1996). However, 
it cannot be ruled out that the association of hlCaP-S175A and hlCaP-S175D with 
actin filaments in cells could be indirectly and mediated by binding tropomyosin 
(Takahashi et al., 1988) or caldesmon (Graceffa et al., 1996).
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On the other hand, cells overexpressing hlCaP-Serl75/254A and hlCaP- 
Serl75/254D show low levels of colocalization of the GFP-tagged proteins with actin 
filaments and the proteins are mainly found in the cytoplasm and the nucleus, 
regardless of the type of mutation (Fig. 11D and E). The fact that the double-mutation 
constructs showed similar defects, this does not allow determination of whether the 
low levels of colocalization are due to the negative charges of the aspartates that 
mimic phosphorylation or to a critical role of both serines in mediating hlCaP actin 
binding. Another aspect that has not been addressed yet in live cells regards the 
tyrosine phosphorylation of hlCaP. Sodium orthovanadate (Na3V 04) is a broad- 
spectrum inhibitor of tyrosine phosphatases. It binds to and blocks the active sites of 
phosphatases, and hence phosphatases can no longer dephosphorylate their target 
proteins. Therefore, I transfected A7r5 cells with GFP-tagged hlCaP and incubated 
these cells with Na3V 04 for 30 minutes to block the activity of tyrosine phosphatases; 
no differences between treated and non-treated cells was detected (data not shown). 
These results further suggest that tyrosine phosphorylation is not the main regulatory 
mechanism of the actin-binding activity of hlCaP in live cells.
Figure 11. (page 70) Subcellular localization of hlCaP constructs tagged with GFP in 
A7r5 cells. (A) HlCaP is observed on stress fibres and a less intense signal of GFP is 
observed in the cytoplasm. (B) Mutation of Serl75 for an alanine or (C) aspartate did 
not affect the localization of hlCaP. (D) Mutation of the Serl75 and Ser 254 for an 
alanine or (E) aspartate significantly affected the cellular localization of hlCaP.
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3.2 The CH domain of hlCaP is required but not sufficient for actin binding
Unlike the type 1 CH domains, the biological role of the type 2 and 3 CH 
domains is still unclear since they both lack actin-binding activity. However, it is 
assumed that the type 2 CH domains cooperate with type 1 CH domains to bind actin 
filaments (Lorenzi and Gimona, 2008). It was shown before that the CH domain of 
hlCaP does not bind to actin filaments and to date there is no clear concept for its 
biological function (Gimona and Mital, 1998). While the CLIK23 repeats directly 
interact with actin filaments (Galkin et al., 2006) and the C-terminal tail of hlCaP 
negatively regulates the actin-binding activity of hlCaP (Burgstaller et al., 2002) there 
is no clear evidence for a potential contribution of the CH domain to the actin-binding 
activity of hlCaP. Therefore in an attempt to gain more information about the 
contribution and the behaviour of the CH domain and the C-terminal tail of hlCaP on 
the actin-binding activity in cells, I have used GFP- labelled hlCaP probes to study 
their localization within the cell. A7r5 cells were transfected with: 1) full length 
hlCaP (hlCaP); 2) hlCaP without the tail (hlCaPAT); 3) hlCaP without the CH 
domain (hlCaPACH); and 4) hlCaP without the CH domain and the tail 
(hlCaPACHAT). The cells were fixed and observed under an upright fluorescence 
microscope, and phalloidin staining was performed to visualize F-actin. Figure 12 
shows minor variations in stress fibre localization between hlCaP and hlCaPAT (Fig. 
12A and B). HlCaP is mainly associated with stress fibres and a weak fluorescent 
signal is observed in the cytoplasm. In contrast, hlCaPAT is almost exclusively 
observed on stress fibres. These data are in agreement with previous results that have 
demonstrated that hlCaP lacking its C-terminal tail is more strongly retained in an 
insoluble cytoskeletal fraction (Burgstaller et al., 2002; Danninger and Gimona,
2000). On the other hand, hlCaPACH failed to prominently decorate actin stress
71
fibres (Fig. 12C), and a stronger GFP signal is observed in the cytoplasm, suggesting 
that hlCaP without the CH domain binds poorly to actin filaments. This suggests that 
the CH domain influences the interaction of hlCaP with actin filaments; however, it 
was shown previously that the CH domain of hlCaP does not bind actin filaments 
directly (Gimona and Mital, 1998). Therefore, it is possible that the CH domain of 
hlCaP plays a regulatory role on the actin-binding activity of hlCaP. Interestingly, 
the localization of hlCaP ACHAT is similar to that observed for full-length hlCaP 
(Figl2A and D). This hlCaP ACHAT comprises mainly the CLIK23 repeats, which is 
the domain responsible for the actin-binding activity of hlCaP.
These results, together with previous biochemical studies on hlCaP (Bartegi et 
al., 1999; Burgstaller et al., 2002; Danninger and Gimona, 2000; Galkin et al., 2006; 
Gimona and Mital, 1998) allow new hypotheses to be explored as to how the actin- 
binding activity of hlCaP is regulated. Figure 12C and 12D demonstrate a possible 
scenario in which the absence of the CH domain favours an interference of the C- 
terminal tail of hlCaP with the actin-binding region. Therefore, one can assume that 
the documented negative effect of the C-terminal tail on the actin-binding activity of 
hlCaP is blocked by the presence of the N-terminal CH domain. Furthermore, 
intrinsic regulatory mechanism may explain the observation of two hlCaP 
conformations (Stafford et al., 1995). One conformation could be mediated by the 
interaction between the CH domain and the C-terminal tail, allowing CLIK23 repeat- 
mediated actin binding. The second conformation could be characterized by the
9 3interaction between the acidic tail with the positively charged residues on the CLIK 
repeats which inhibits the actin-binding activity of hlCaP.
To test this hypothesis of a potential influence of the C-terminal tail on the
•  9 3actin-binding activity of the CLIK repeats I generated two constructs coding for the
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CLIK23 repeats with (CLIK) or without the C-terminal tail (CLIKAT) tagged with 
GFP. The constructs were transfected in A7r5 cells to analyze their subcellular 
localization. Figure 13 shows that the CLIK23 repeats without the tail are able to 
decorate actin filaments (Fig. 13B), whereas the CLIK23 repeats with the tail fail to do 
so (Fig. 13C). This result suggests that the tail exerts its inhibitory effect by 
interfering with the actin-binding activity of the CLIK repeats.
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Figure 12. Subcellular localization of hlCaP constructs. (A) HlCaP is observed 
mainly on stress fibres and partially in the cytoplasm (see also Fig. 1A). (B) The tail- 
deleted form of hlCaP is only found on stress fibres. (C) Most of the CH domain- 
deleted form of hlCaP is observed in the cytoplasm. (D) HlCaP lacking both the CH 
domain and the tail localizes mainly with stress fibres and there is little in the 
cytoplasm.
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Figure 13. Subcellular localization of hlCaP and the isolated CLIK23 repeat module 
tagged with GFP. (A) Most of HlCaP localizes with stress fibres (See also Fig. 1A 
and 2A). (B) The CLIK23 repeats lacking the C-terminal tail are found mainly on 
stress fibres and to some extent inside the nucleus. (C) The CLIK23 repeats carrying 
the tail localize mainly in the cytoplasm of the cells as well as in the nucleus.
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3.3 In silico interaction of the CH domain and the tail of hlCaP
As a first approach to examine whether the CH domain and the tail of hlCaP 
interact, a molecular docking algorithm (FTDOCK) was used (Gabb et al., 1997; 
Katchalski-Katzir et al., 1992). This programme requires the crystal or solution 
structure of the two molecules that are to be docked. While the solution structure of 
the CH domain of hlCaP was solved a few years ago (Bramham et al., 2002), the 
structure of the rest of the protein remains elusive. Thus the shape of the C-terminal 
tail of hlCaP was modelled by sequence homology. The amino-acid sequence of the 
tail was blasted (NCBI Blastp), and a portion of the sequence of the creatine kinase 
protein showed 33% homology at the amino-acid level (Fig. 14).
L N P E Y P E L S E P T H N H H P H N Y Y N S A  T a i l  o f  CaPhl (L274 to  A297)
S E E E Y P D L S — KHNNHMAKVIjTP D  C r e a t in e  k in a s e  sequence (S16 to  D37)
Figure 14. Comparison of the amino-acid sequences of the C-terminal tail of hlCaP 
and the homologous sequence of creatine kinase. (+ similar charges)
Therefore the known crystal structure of this portion of creatine kinase was 
used as template to model the shape of the hlCaP tail (Fig. 15). The quality of the tail 
structure was evaluated with the HOPPscore application (Sims and Kim, 2006) and 
with the Ramachandran plot from the VMD molecular graphic programme 
(Humphrey et al., 1996).
FTDOCK requires a static molecule to fit a ligand. Thus, the CH domain was 
assigned as static and the tail was used as a free molecule to be positioned around the 
CH domain. The same analysis was performed with a scrambled tail sequence
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Creatine kinase crystal structure homologous sequence in hlCaP
CaPhl tail after modelling Ramachandran plot
Figure 15. Homology modelling of the C-terminal tail of hlCaP. The known structure 
of creatine kinase was used as template to model the shape of the tail. The final 
structure was evaluated with the HOPPscore application and with the Ramachandran 
plot.
(tailScmbl) and with the creatine kinase sequence as, controls. The tailScmbl was 
generated by randomly mixing the residues of the hlCaP tail, while for the second 
control, the sequence of creatine kinase corresponding to the homology sequence of 
the tail was used.
Unlike the two controls, the tail was positioned predominantly facing the helix 
A and loop 1 of the CH domain (Fig. 16 A), with a large contact area, and six out of 
the 10 best results were positioned at almost identical positions. On the other hand, no 
contact area was seen between the scrambled tail and the CH domain, and the tail was 
oriented away from the CH domain, with a prediction for interaction with just one 
single residue (Fig. 16B). In addition, the docking of the creatine kinase sequence 
onto the CH domain did not show any preferential position (Fig. 16C).
To extend the above analysis, the primary regions and residues predicted to be 
involved in the interaction between the hlCaP CH domain and tail were identified 
(Fig. 17). The molecular surface was computed with AutoDockTools 1.5.1 (Sanner, 
1999) and the electrostatic surface potentials with the APBS algorithm (Baker et al.,
2001). When the surface volume and charges are assigned to the docked parts of the 
CaP molecule, both the surface profiles and charge oppositions matched. The tail 
showed a cleft into which the Arg44 of the CH domain can be inserted. Arg45 and 
Asn49, which are also positioned on helix A/loop 1 of the CH domain, might 
contribute to the stabilization of this interaction.
Electrostatic interactions play an important role in determining the 
thermodynamics of binding and they can influence long-range attractions between the 
substrate and the ligand (Gabdoulline and Wade, 2002). The favourable charge -  
charge interactions between the ligand and the receptor help in the formation of the 
complex and stabilizing low energy interactions such as salt bridges and hydrogen
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bonds (Chong et al., 1998; Schreiber and Fersht, 1995). However, the affinity 
between the ligand and the receptor molecule must be strong enough to shed their 
bound water molecules in order to allow close binding. Therefore, the solvation and 
binding energies of the complex resulted from the FTDOCK were calculated. The 
results are summarized in Table 3. Fastcontact 2.0 (Camacho and Zhang, 2005) was 
used to analyze the major residues that may contribute to the electrostatic energy (4r) 
between the CH domain and the tail. The best three residues of the CH domain 
identified using Fastcontact were Arg44, Arg45 and Asn49 with 4r of -20.54, -19.04 
and -20.78 kJ/mol respectively. On the other hand, the best three residues of the tail 
were Glu280, Asn292 and Tyr293 with 4r of -24.65, -10.07 and -9.94 kJ/mol, 
respectively. In addition, with Fastcontact it was possible to identified the major 
receptor-ligand residue electrostatic contacts, which included Asn49 -  Glu280, Arg44 
-  Glu283 and Arg45 -  Asn292, with 4r o f -16.34, -11.57 and -11.57 kJ/mol, 
respectively. Although the electrostatic energies at the single residue level are high, 
the calculated binding energy of the complex formed by the tail and CH domain 
region comprising the helix A and the loop 1 is relatively low (table 3). Indeed, 
immunoglobulin binding energies range from -20 kJ/mol to -130 kJ/mol (Schwarz et 
al., 1995). However, low binding energies might account for a more dynamic 
interaction.
AG solvation 
(kJ/mol)
Binding energy 
(kJ/mol)
tail -2814.52 -
CH domain -2922.87 -
complex -5363.59 -5.36
Table 3. Solvation and binding energies calculated with the APBS algorithm (Baker 
et al., 2001). Only the region comprising the helix A and the loop 1 was used for the 
energy calculations of the CH domain. Energies were calculated considering the 
solvent dielectric of water (78.54) at 298.15 K (25 °C).
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Figure 16. Docking the C-terminal tail onto the CH domain of hlCaP. (A) The tail is 
predicted to contact with the helix A and loop 1 of the CH domain. The best three 
docking results are in similar positions. (B) No contact area is seen between the 
scrambled tail and the CH domain, and the tail is oriented away from the CH domain 
interacting with just one residue. (C) The docking of the creatine kinase sequence 
onto the CH domain does not show any predominant position.
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Figure 17. Analysis of the regions involved in the interaction between the CH domain 
and the tail of hlCaP. The surface electrostatic potentials were mapped in MGT tools 
using APBS (Baker et al., 2001) (A) Surface with charges of the complex formed by 
the tail and the CH domain. Positive charges are represented in blue and negative 
charges in red shadings. (B) A red line marks the limits between both domains. (C) 
The CH domain and the tail were separated and rotated in order to observe the 
residues involved in the interaction. The arrows mark the Arg44 and Arg45 of the CH 
domain. The CH domain is inserted into the cleft of the tail. (D) A second area of 
contact comprising Asn49 of the CH domain is revealed when the complex is viewed 
from a different angle.
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3.4 The hlCaP CH domain and the tail interact in vitro
To further explore the significance of the intramolecular interaction between 
the hlCaP CH domain and the tail, both domains were used to perform an in-vitro 
overlay assay. His-tagged (CHD-His) or GST-tagged (GST-CHD) CH domains, and 
the tail tagged with GST and myc (GST-tail-myc) were expressed in bacteria and 
purified. Either the CH domain or the tail were immobilized on a nitrocellulose 
membrane and incubated with a solution containing the ligand. Specific antibodies 
against the tags present on the proteins in solution (ligand) where used to detect 
binding. When GST-tail-myc was immobilized on the nitrocellulose membrane the 
CHD-His was detected bound to the tail and no signal was detected in the controls 
(Fig. 18C). Similar results were obtained using the GST-CHD or CHD-His as the 
immobilized molecule (Fig. 18A and B). In both cases the tail was detected bound to 
the CH domain. This data strongly suggests that the tail and the CH domain interact 
directly. However, the requirement for the addition of paraformaldehyde to maintain 
the interaction suggests that the interaction between the hlCaP CH domain and the 
tail is weak.
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Figure 18. In-vitro interaction between the hlCaP CH domain and tail. (A) The CH 
domain tagged with His for detection was immobilized on a nitrocellulose membrane 
and incubated with a solution containing the tail tagged with GST and myc. After 
several washes the tail was detected with an anti-myc antibody. (B) The tail of hlCaP 
interacts with a GST-tagged CH domain. (C) The tail tagged with a GST and myc was 
immobilized on a nitrocellulose membrane and incubated with a solution containing 
the CH domain tagged with His. After several washes the CH domain was detected 
using an anti-His antibody.
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3.5 Helix A and the loop 1 of the hlCaP CH domain are involved in the 
regulation of its actin-binding function
The results obtained from the in-silico docking studies between the hlCaP 
CH domain and tail suggested that helix A and loop 1 of the CH domain are involved 
in mediating this interaction. Therefore, a recombinant hlCaP lacking the potential 
region of interaction in the CH domain should show reduced actin-binding activity.
To examine whether the helix A and loop 1 of the CH domain of hlCaP play a role in 
the actin-binding function of hlCaP I generated two constructs where the helix A and 
the loop 1 of the CH domain were deleted (hi CaPAHxAALl) and tagged with either 
myc or GFP for detection. Deletion of helix A and loop 1 of the CH domain 
significantly reduced the actin-binding activity of hlCaP (Fig. 19 and 20). This result 
is in agreement with the underlying hypothesis that the hlCaP CH domain modulates 
the inhibitory role of the hlCaP C-terminal tail.
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Phalloidin
hlCaP
hi CaPAHxAALl
Figure 19. Subcellular localization of myc-tagged hlCaP constructs in A7r5 cells. (A) 
HlCaP localizes preferentially with stress fibres and little is found in the cytoplasm. 
(B) HlCaP lacking the helix A and the loop 1 of the CH domain is mainly found in 
the cytoplasm.
Phalloidin
hlCaP
hi CaPAHxAALl
Figure 20. Subcellular localization of GFP-tagged hlCaP constructs. (A) HlCaP 
localizes preferentially with stress fibres and little is found in the cytoplasm of the 
cell. (B) HlCaP lacking the helix A and the loop 1 of the CH domain is mainly found 
in the cytoplasm.
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3.6 The CH domains of CaP, SM22 and Vav are not interchangeable
Although CH domains from different proteins have low sequence similarities, 
a few defined residues are almost always invariant. These core residues are thought to 
be the major factors involved in establishing the three dimensional structure of the CH 
domain (Gimona et al., 2002), and the differences observed in the sequences explain 
the functional diversity observed among the CH domains. HlCaP, Vav and SM22a 
have in common a type 3 CH domain (Fig. 21). The CH domain of Vav has been 
found to regulate the transforming activity of the protein through an intramolecular 
interaction with the zinc finger (ZF) and Dbl homology (DH) domains (Zugaza et al.,
2002), and a similar regulatory mechanism has been reported for ARHGEF6 (Daniels 
et al., 1999). Therefore, type 3 CH domains might serve a general intramolecular 
regulatory function.
Sequence comparisons between the CH domains of SM22, Vav and hlCaP 
show differences in the helix A and loop 1 (Fig. 21). The predicted residues involved 
in the interaction between the hlCaP CH domain and the tail are missing in both, 
SM22 and Vav. Thus, to extend the analysis, the CH domain of hlCaP was replaced 
by the CH domain of SM22 and Vav in order to investigate whether the regulatory 
function that was identified in the CH domain of hlCaP is conserved in other type 3 
CH domains. HlCaP carrying the CH domains of SM22a (hlCaP-SMCH) or Vav 
(hlCaP-VavCH) were generated as GFP fusion cDNA constructs and cells were 
transfected with these probes. Phalloidin was used to visualize F-actin. .
Figure 22 shows that neither the CH domain of Vav nor that of SM22a is able 
to substitute for the CH domain of hlCaP. HICaP-SMCHD poorly decorates actin 
filaments and a stronger cyoplasmic fluorescent signal is observed (Fig. 12A and C); 
its localization in the cell resembles more the predominantly cytoplasmic localization
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of GFP SM22a (Fig. 22B and C). The exchange of the hlCaP CH domain for the CH 
domain of Vav reveals a similar picture, and hlCaP-VavCH also failed to associate 
with actin filaments (Fig 22A and E).
These results support the concept that type 3 CH domains have distinct 
functions in different molecular species. Although they share a few common core 
residues that allow similar three dimensional structures, they are functionally diverse. 
The CH domain of Vav and SM22a appear unable to interact with the C-terminal tail 
of hlCaP, and hence, to alleviate the block on the actin-binding activity in hlCaP. 
Interestingly, the predicted residues of hlCaP involved in the binding of the tail 
(Arg44, Arg45 and Asn49, see section 3.3) are not present in SM22a, and only Arg45 
is present in Vav (Fig. 21).
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Figure 21. Alignment of the CH domain sequences of hlCaP (CaP), SM22a and 
Vavl. Conserved residues are highlighted in blue and the hlCaP residues involved in 
the interaction with the C-terminal tail are marked with black squares.
Figure 22. (page 89) Subcellular localization of SM22a, Vavl and hlCaP constructs. 
(A) HlCaP is mainly found on stress fibres of cells. (B) SM22a localizes mainly in 
the cytoplasm of cells and associates poorly with stress fibres in formaldehyde-fixed 
cells. (C) HlCaP canying the CH domain of SM22a is found in the cytoplasm as well 
on stress fibres of the cells. (D) Vavl is found in the cytoplasm as hlCaP canying the 
CH domain of Vav (E).
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3.7 Molecular proximity of the CH domain and the tail of hlCaP
The data presented thus far indicate that the CH domain and the tail of hlCaP 
interact in vitro. However, it is important to analyze whether this interaction can also 
occur in live cells. Thus, fluorescence resonance energy transfer (FRET) was used to 
analyze whether the CH domain and the tail are in close enough proximity to allow a 
physical interaction. For this purpose, hlCaP was cloned into the pCDNA mammalian 
expression vector and fused to a citrine (YFP) and cyan fluorescence protein (CFP) at 
the N- and C- terminus, respectively (Y-hlCaP-C). A7r5 cells were transfected and 
FRET was measured under a Zeiss LSM510 META confocal microscope, using the 
donor dequenching technique (Bastiaens and Jovin, 1996; Szaba et al., 1992). This 
technique is based on the fluorescence recovery of the donor after acceptor bleaching. 
When the CFP of Y-hlCaP-C is excited two emission peaks are observed, one at 490 
nm, corresponding to the CFP emission, and a second at 530 nm, corresponding to the 
emission of the YFP (Fig. 23A and B). The intensity of the second peak suggests that 
energy transfer occurs between the CFP and YFP. Indeed, the intensity of the CFP is 
seen to increase when the YFP is bleached, suggesting that part of the CFP energy 
was transferred onto the YFP (Fig. 24A). This effect is not observed in Y-hlCaPAT-C 
where the tail is not present (Fig. 24B) indicating that the N-terminal CH domain is 
close to the C-terminus of the hlCaP only in the presence of the acidic tail (Fig. 24C). 
The data obtained from measuring the CFP-fluorescence changes of Y-hlCaP-C and 
Y-hlCaPAT-C was analyzed with the statistical student’s x-test, which resulted in a p- 
value of 0.045.
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Figure. 23. Subcellular localization and CFP excitation of the hlCaP FRET sensor. 
(A) Excitation of CFP produces two peaks of excitation, one between 473 nm and 494 
nm and a second peak between 526 nm and 537 nm. (B) Excitation spectra of hlCaP 
upon CFP excitation in the region of interest (ROI). The ROI is marked with a red 
box.
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Figure 24. (page 92) Energy transfer of hlCaP constructs carrying and N-terminal 
YFP and a C-terminal CFP. (A) Bleaching the YFP of hlCaP induces an increment in 
the fluorescence intensity of the CFP. (B) Bleaching the YFP of hlCaP lacking the C- 
terminal tail does not increase the fluorescence of the CFP. (C) Measurement of the 
relative changes in the fluorescence intensity of the CFP after bleaching the YFP. The 
control is the change of fluorescence intensity of CFP in a non-bleached area. 
Student’s x-test with one tail and with unequal variance gave a statistical p-value of 
0.045.
3.8 The C-terminal tail controls the actin-binding dynamic of h lC aP
It has previously been shown that the C-terminal tail of hlCaP negatively 
regulates the hlCaP actin-binding activity (Burgstaller et al., 2002). A direct approach 
to analyze protein dynamics in cells is the use of fluorescence recovery after 
photobleaching (FRAP). FRAP utilizes the phenomenon of photobleaching of 
fluorescent probes to measure molecular mobility. Thus, A7r5 cells were transfected 
with the GFP tagged probes of hlCaP, hlCaPAT, hlCaPACHD and hlCaPACHDAT, 
to study their cellular dynamics. FRAP was performed under a Zeiss LSM510 
confocal microscope, and the region of interest was bleached using 100% intensity of 
the 488 nm laser. Images were acquired before and after bleaching and a third image 
was taken after 2 or 5 minutes to avoid excessive bleaching of the sample. The results 
show a relatively high stability for full-length hlCaP. While GFP can recover 90% of 
the fluorescence 10 seconds after the bleaching time (Goodwin and Kenworthy, 2005; 
Swaminathan et al., 1997), the fluorescence recovery of hlCaP after bleaching was 
approximately 40% in 5 minutes (Fig. 25A). This slow recovery rate was even more 
pronounced in hlCaP lacking the tail (hlCaPAT) (Fig. 25A), suggesting a slower 
turnover for this construct on actin filaments, as was proposed earlier (Burgstaller et 
al., 2002). On the other hand, the fluorescence of hlCaPACHD and hlCaPACHDAT 
was rapidly recovered (Fig. 25B), and after 2 minutes of the bleaching time, 80% and 
90% of the fluorescence was recovered, respectively. These results strongly suggest
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that both the CH domain and the tail are involved in the regulation of the actin- 
binding activity of hlCaP. In addition, the hlCaPACHDAT construct was expected to 
have recovery rate similar to hlCaP, which it doesn’t (Fig. 25A and B). The fast 
fluorescence recovery observed with the hlCaPACHDAT could be due to an 
impairment of its regulatory mechanism.
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Figure 25. Fluorescence recovery after bleaching of GFP-tagged hlCaP constructs. 
(A) Recovery of hlCaP is 45% after 5 minutes. The recovery of hlCaP lacking the 
tail is 25%. (B) HlCaP lacking the CH domain or the CH domain and the tail shows 
faster recoveries. After 2 minutes more than 70% of the fluorescence of hlCaPACHD 
was recovered, and almost 90% for hlCaPACHDAT.
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CHAPTER 4: RESULTS II
4.1 Calponins localize at the ingression furrow and the contractile ring
Two prominent actin-rich structures are formed during mammalian 
cytokinesis, namely the cleavage furrow and the contractile ring. These two structures 
contain myosin II, which facilitates furrow ingression and the constriction of the 
plasma membrane of cells, which is necessary to separate the mother cell into two 
daughter cells. During metaphase, cells round up and at the beginning of anaphase 
cells elongate, forming a cylindrical shape, and a furrow begins to ingress in the same 
plane where the contractile ring is localized (Robinson and Spudich, 2004). Although 
actin and myosin II are key players in the formation and function of these structures, 
the presence of ABPs is also important (Reichl et al., 2008). These allow propagation 
of the tension generated by myosin into the crosslinked actin network and to the 
plasma membrane.
HlCaP was discovered in an attempt to identify troponin related proteins in 
smooth muscle, and most experiments have focused on its actin-binding activity and 
regulation of smooth muscle contraction. It was shown that overexpression of hlCaP 
can reduce cell proliferation and tumorigenicity of several cell lines (Lener et al., 
2004; Ogura et al., 2006). Furthermore, an increment of binucleated cells is observed 
in cells transfected with hlCaP suggesting a role of hlCaP during cell division (Lener 
et al., 2004). Since hlCaP is an ABP and inhibits the actin-activated ATPase activity 
of myosin II it could also play an important role during cytokinesis. Therefore I have 
used an antibody against hlCaP to detect the endogenous protein, and transfected 
A7r5 cells with the three calponin isoforms tagged with GFP to monitor their 
localization during mitosis. HlCaP (Fig 26A, B and C), h2CaP (Fig. 27A) and h3CaP
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(Fig. 27B) all localized to the ingression furrow. Before the ingression of the furrow, 
these CaPs accumulate at the cell periphery marking the area where the ingression of 
the furrow starts. Confocal images and thre dimensional projections of confocal 
images show the localization of endogenous hlCaP with the contractile ring (Fig. 28).
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tubulin hlCaP
Figure 26. Subcellular localization of endogenous hlCaP and microtubules in A7r5 
during cytokinesis. (A) HlCaP localizes at the ingression furrow at both sides of the 
cell equator. (B) HlCaP localizes at the ingression furrow and the contractile ring. (C) 
HlCaP is found in the contractile ring.
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Figure 27. Subcellular localization of GFP tagged (A) h2CaP and (B) h3CaP in live 
A7r5 cells. Both proteins localize at the ingression furrow during anaphase.
Figure 28. Three dimensional projection of confocal images of endogenous hlCaP. 
HlCaP is observed in the contractile ring (a to e).
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4.2 Overexpression of hlCaP mutants induce defects in cell division
The finding that hlCaP localizes at the ingression furrow and the contractile 
ring raises several questions. Does hlCaP regulate cell division? If so, which phase 
and how is it regulated? As shown before, phosphorylation might not be relevant for 
the actin-binding function of hlCaP in interphase cells, however, it could be relevant 
during cell division. Furthermore, the CH domain and the tail, which can regulate 
hlCaP dynamics, could also play a role during cell division. Indeed, overexpression 
of hlCaP lacking the C-terminal tail and tagged with GFP (hlCaPAT) induced defects 
in cells division (Fig. 29). This cell division impairment ranges from a block of 
ingression furrow formation and progression (Fig 29A and B) to impairment of 
abscission (Fig 29C and D) and mislocalization of the ingression furrow (Fig 29E). A 
block in metaphase is observed in cells overexpressing hlCaP-S175/254A tagged 
with GFP in A7r5 cells (Fig. 30A), while cell division progresses normally in cells 
overexpressing hlCaP-S175/254D, which mimics serine phosphorylation (Fig. 30B).
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Figure 29 (pages 100 -101). Subcellular localization and effects of tail-deleted 
hlCaP during cell division. (A) HlCaPAT localizes at the ingression furrow, but the 
furrow does not progress. (B) HlCaPAT localizes at the cell periphery during 
metaphase but there is no formation of the furrow and anaphase does not initiate. (C) 
HlCaPAT localizes at the cell periphery during metaphase. A cell in interphase is 
observed without going through the anaphase. (D) HlCaP localizes to the ingression 
furrow. Despite a normal anaphase, the two daughter cells do not separate. (E) HlCaP 
localizes to only one side of the equator without the formation of the ingression 
furrow.
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Figure 30. Subcellular localization and effects of hlCaP Seri 75 and 254 mutants in 
live A7r5 cells. (A) CaP-S175/254A is observed in the cytoplasm and cell division 
does not progress. (B) CaP-S175/254D is observed in the cytoplasm and cell division 
progresses normally.
102
CHAPTER 5: DISCUSSION
The actin cytoskeleton is regulated by ABPs, which are involved in the 
dynamic assembly and disassembly of actin filaments. ABPs regulate actin dynamics 
by promoting actin polymerization and the severing of actin filaments, sequestering 
actin monomers, or crosslinking and stabilizing actin filaments into networks and 
bundles. The actin cytoskeleton is under constant regulation in many physiological 
and pathological situations, such as cell division, locomotion and cell differentiation. 
Many human disease conditions such as cancer, chronic inflammation and 
angiogenesis are characterized by an increase in cell locomotion, where cells escape 
from a tissue, reach and cross the endothelial cell barriers of the blood vessels, and 
infiltrate other tissues. All these steps require constant adaptations of the actin 
cytoskeleton. Thus, defining the mechanisms that underlie the actin-binding activities 
of ABPs will lead to a better understanding of how these proteins work and of their 
involvement in human diseases. In this study an attempt was made to describe the 
molecular mechanism that regulates the actin-binding activity of hlCaP.
5.1 HlCaP phosphorylation
In vitro phosphorylated hlCaP cannot associate with actin filaments (Winder 
and Walsh, 1990b). This finding suggests that cells exploit this type of post- 
translational modification to regulate the actin-binding activity of hlCaP. HlCaP can 
be phosphorylated by PKC (Winder and Walsh, 1990b), ROCK (Kaneko et al., 2000), 
Ca27CaMKII (Winder and Walsh, 1990a) and Fyn (Abouzaglou et al., 2004), 
however it is not known if these processes also occur in vivo. In addition, the 
phosphorylation sites are not accessible when CaP is associated with actin filaments 
(Nagumo et al., 1994). Thus other mechanism(s) must regulate the interaction of
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hlCaP with F-actin. I have first analyzed the role of serine 175 phosphorylation in 
cells, which has been described as the main phosphorylated residue in hlCaP (Winder 
et al., 1993a). It was previously shown that the S175A mutation weakens the binding 
of hlCaP with actin filaments in vitro implying a crucial role of the hydroxyl side 
chain in position 175 in the interaction of hlCaP with actin (Tang et al., 1996; Uyama 
et al., 1996). In the same study, a S175T mutant did not affect the binding activity of 
hlCaP, confirming the importance of a phosphorylatable hydroxyl side chain in the 
binding activity of hlCaP. Even more, a S175D mutant showed very similar effects 
to those of Serl75A supporting the hypothesis that a hydroxyl group at position 175 is 
necessary for hlCaP to bind actin filaments and that phosphorylation inhibits the 
binding activity. However substitution of Serl75 for an aspartate or alanine in fixed 
cells (shown in this study) and live cells (data shown) did not affect the ability of 
hlCaP to associate with actin thin filaments. Therefore, the presence of Serl75 might 
not be as crucial in cells as it is in vitro since the dramatic effects on the actin-binding 
activity of hlCaP in vitro is not observed in cells. In contrast, the double mutation of 
Serl75 and Ser254 resulted in low levels of colocalization with actin filaments 
regardless of the presence of an alanine or aspartate. Based on the observations of 
Tang et al. 1996, two scenarios could explain these results: in the first scenario the 
hydroxyl groups of Serl75 and Ser254 would be the major contributors for the hlCaP 
binding with actin filaments. In the second scenario, Ser254, and not Serl75, would 
be the critical residue for the actin-binding activity of hlCaP. The first scenario can be 
questioned because in the present study, it is shown that mutations of Serl75 do not 
affect the actin-binding function of hlCaP in cells. However, earlier experimental data 
showed that phosphorylation of Serl75 changed hlCaP conformation (Jin et al.,
104
2000), which could then expose Ser254 to kinases, and lead to a reduction in the 
affinity of hlCaP for actin filaments.
It was found that Tyrl82 and Tyr261 of hlCaP are phosphorylated in vitro by 
the Src family kinase Fyn, and that tyrosine phosphorylation significantly reduces the 
affinity of hlCaP for actin filaments (Abouzaglou et al., 2004). Therefore, I analyzed 
the cellular localization of hlCaP in cells incubated with NaV04, which did not differ 
from that in untreated cells. These data suggest that phosphorylation does not 
represent the major regulatory mechanism for hlCaP activity in cells. However, other 
hlCaP phosphorylation sites have been described, such as Thrl84 (Nakamura et al., 
1993), Ser71, Ser215 (Winder et al., 1993a), Thr 170, Thrl80 and Thr 259 (Kaneko et 
al., 2000). Those residues are not as extensively phosphorylated as Serl75 and 
Ser254, thus they were not included in this analysis.
Both Serl75 and Ser254 of hlCaP are within conserved PKC-substrate 
consensus sequences (Kennedy and Krebs, 1991; Pearson and Kemp, 1991), which 
may explain the preference of PKC for these sites. However, the existence of a 
phosphorylatable consensus sequence in proteins does not ascertain that a protein is 
phosphorylated. Although hlCaP is efficiently phosphorylated in vitro, it is possible 
that in vivo hlCaP does not interact with PKC, or that the serines are not accessible to 
the kinase. Indeed, colocalization was not observed between hlCaP and PKCs in 
resting A7r5 cells (data not shown). Nevertheless, PKC might interact and 
phosphorylate hlCaP in diverse physiological situations in vivo.
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5.2 Intramolecular interaction between the CH domain and the tail of hlCaP
The regulation of hlCaP at the molecular level is poorly understood. 
Regulation by phosphorylation is discussed above (see 5.1) and does not appear to be 
the major regulatory mechanism for the actin-binding activity of hlCaP. On the other 
hand, Ca2+ binding proteins such as CaM and S100 block the inhibitory function of 
hlCaP on the actin-activated ATPase activity of myosin in vitro (Kolakowski et al., 
1995). In addition, it was shown that the CH domain of hlCaP binds to ERK, PKCe 
and PKCa (Leinweber et al., 2000; Menice et al., 1997). However, the physiological 
relevance of these interactions is not known.
One study attempted to formulate a regulatory mechanism based on the 
inhibition of the actin-binding activity by the C-terminal tail of CaPs (Burgstaller et 
al., 2002). Interestingly, the tail-deleted forms of hlCaP and h2CaP showed a higher 
affinity for actin filaments in a biochemical assay that measures the amount of protein 
in cellular fractions with or without actin filaments. Therefore, the C-terminal tail of 
CaPs was postulated to regulate their actin-binding activity either by interfering with 
the ABS or by interacting with other regulatory proteins. In the present study, I have 
analyzed several hlCaP mutants in order to shed more light on the contribution of the 
CH domain and C-terminal tail on the actin-binding activity of the protein. I have 
demonstrated by fluorescence microscopy analysis that the C-terminal tail of hlCaP 
indeed affects its association with actin-containing thin filaments, which is even more 
pronounced when the CH domain is also missing. Therefore, the presence of the CH 
domain is able to suppress the actin-binding inhibitory function of the C-terminal tail. 
Indeed, I have shown that the CH domain binds to the C-terminal tail in in-vitro 
overlay assays. One can thus propose that the CH domain and the tail of hlCaP are 
the major functional modules that are responsible for the regulation of the actin-
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binding activity of the protein. The interaction between these domains in vivo could 
influence the dynamics of the protein and modulate the strength of its binding to actin 
filaments. I have also shown by FRET analyses that the CH domain and the tail of 
hlCaP are in close proximity, and that the CH domain and the C-terminal tail of 
hlCaP regulate the protein dynamics in live cells. HlCaP and its tail-deleted form 
have slow fluorescence recovery times, suggesting that they are tightly associated 
with actin filaments. In contrast, hlCaP mutants lacking either the CH domain alone 
or both the CH domain and the tail show faster fluorescence recovery, which 
indirectly points towards a reduced affinity for actin filaments.
5.3 A hypothetical model for the molecular mechanism that regulates hlCaP- 
actin interaction
Considering the results of this study together with the conclusions of 
Burgstaller et al. 2002, a more detailed picture of the regulatory mechanism of the 
actin-binding activity of hlCaP is starting to emerge. Two flexible domains, the C- 
terminal tail and the N-terminal CH domain together appear to regulate hlCaP-actin 
binding. The actin-binding activity of hlCaP could be induced by an interaction 
between both of these terminal domains, which exposes the actin-binding interface 
generated by the triple CLIK23 repeats. When the intramolecular contact between the 
CH domain and the tail is released (by a yet to be defined mechanism), the tail 
interacts with the CLIK23 repeats and interferes with the actin-binding activity (Fig. 
31). This mechanism requires to some extent a flexible protein that can shift between 
two conformations. Indeed, molecular flexibility has been observed in electron 
microscopy images of hlCaP (Stafford et al., 1995). Even more, the CLIK23 repeats 
follow the consensus of a type I intrinsically unstructured protein (IUP)
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CH
domain
bound to actin filaments
dissociation from actin filaments
A B
Figure 31. Hypothetical model of the two molecular states of hlCaP. (A) The C- 
terminal tail (cyan) of hlCaP interacts with the CH domain (green) exposing the 
CLIK23 repeats (the repeats are in blue and intervening sequences in red) to the actin 
filaments. (B) Factors such as calcium binding proteins bind to the N-terminus of 
hlCaP (yellow) and displace the tail from the binding site of the CH domain. Once 
the tail is free it can interact with the CLIK23 repeats, thus blocking the interaction 
with actin filaments.
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(Czurylo et al., 2000; Stafford et al., 1995), suggesting a high propensity for protein 
flexibility. It is well established that IUPs often behave as flexible strings and that 
binding to a target molecule can induce structural rearrangements and the formation 
of physiologically relevant binding sites (Dyson and Wright, 2005).
Similar regulatory mechanisms that are mediated by the intramolecular 
interaction of two domains have also been described for other ABPs and proteins 
possessing type 3 CH domains. Vinculin is a 117-kDa protein that binds actin 
fdaments and is present in focal adhesions (Geiger et al., 1980). The N-terminal head 
domain of vinculin binds to its C-terminal tail domain, which results in the masking 
of the actin-binding site (Johnson and Craig, 1995a). The vinculin tail binds acidic 
phospholipids that release the interaction with the head and expose the actin-binding 
sites (Johnson and Craig, 1995b). A similar regulatory mechanism has also been 
proposed for the actin-binding activity of the myristoylated alanine-rich C kinase 
substrate (MARCKS) protein and for the Dyctyostelium discoideum 34-kDa F-actin- 
bundling protein (Lim et al., 1999; Tapp et al., 2005). The GEF activity of Vav 
towards Rho and Rac GTPases is regulated by the intramolecular interaction between 
the N-terminal CH domain and the central ZF region of the protein (Zugaza et al., 
2002). The binding of the CH domain to the ZF region results in the inhibition of the 
GEF activity. A similar mechanism was also proposed for the GEF ARHGEF6 or 
aPIX. A CH domain deleted form of ARHGEF6 is constitutively active, suggesting 
that the CH domain regulates the GEF activity of the protein (Daniels et al., 1999). 
These observations on Vav, ARHGEF6 and now hlCaP, suggest that the type 3 CH 
domains might have evolved as regulators of protein activities mediated through 
intramolecular interactions.
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The CH domain -  tail interaction may be regulated by several factors. It was 
shown in vitro that the Ca2+-binding protein caltropin (S100A6) binds to the N- 
terminal region of hlCaP (Wills et al., 1994a) and inhibits the actin-binding activity 
of hlCaP (Wills et al., 1994b). In addition to caltropin, other Ca2+ binding proteins 
including CaM and other S100 family members, can bind to the N-terminal domain of 
hlCaP and block the inhibition of the actin-activated ATPase activity of myosin (Abe 
et al., 1990) and the removal of hlCaP from the actin filaments (Fujii et al., 1994). 
Considering these data and the results of the present study, it is probable that the 
interactions of Ca2+-binding proteins with the N-terminal domain of hlCaP disrupts 
the interaction between the hlCaP CH domain and the tail and reduces its affinity for 
actin filaments. Furthermore, the N-terminal region of hlCaP where Ca2+/CaM and 
caltropin bind, contains the binding area for the C-terminal tail (Mezgueldi et al.,
1992; Wills et al., 1994a). PKCa, PKCs and ERK might also regulate the interaction 
between the hlCaP CH domain and the tail. The physiological relevance of these 
interactions, however, needs to be demonstrated (Leinweber et al., 2000; Menice et 
al., 1997). Nevertheless, the binding of Ca2+/CaM and caltropin is intriguing, since 
they lack enzymatic (e.g. kinase) activity (Crivici and Ikura, 1995).
CaM is 15-kDa protein that is ubiquitously expressed in animals, plants, fungi 
and protozoa (Bazari and Clarke, 1981; Cheung, 1971; Eldik et al., 1980). It functions 
as a cytosolic Ca2+receptor and binds four calcium ions, which induce a 
conformational change that enables Ca2+/CaM to bind its target proteins (Crivici and 
Ikura, 1995; Krebs and Carafoli, 1982). It is possible that CaM and calcium fluxes 
regulate the actin-binding activity of hlCaP. Three-dimensional reconstructions of 
pure F-actin incubated with hlCaP or hlCaPACHD show that the CLIK23 repeats are 
in contact and mediate the binding with the actin filaments, while the N-terminal
110
region comprising the CH domain is not (Galkin et al., 2006). Thus, it is possible that 
the N-terminal region remains accessible for the binding to the C-terminal tail. 
Furthermore, the N-terminal region of hlCaP could also interact with Ca2+/CaM, 
which in turn would free the tail from the CH domain thus inhibiting actin binding. 
The C-terminal tail of hlCaP and Ca2+/CaM might compete for binding to the same 
region of the hlCaP N-terminus. Furthermore, other Ca2+-binding proteins such as 
caltropin and the smooth muscle calcium binding protein (SMCaBP) have 
significantly higher affinities for hlCaP than Ca2+/CaM (Wills et al., 1993; Wills et 
al., 1994b); therefore, they might also regulate hlCaP activity in a similar manner.
As hlCaP only binds to calcium-bound CaM and not to the free form of CaM 
(Winder et al., 1993b), this suggests that intracellular calcium regulates the actin- 
binding activity of hlCaP.
5.4 Regulation of the actin-binding activity of calponin isoforms
All CaPs have a similar domain structure and their amino-acid sequences are 
highly conserved, except for their C-terminal tails, which are different in each 
isoform. The structural similarities suggest that CaPs share similar regulatory 
mechanisms in the cell. The isotype-specific acidic tail sequences might dictate the 
strength of the binding between the CH-domain and the tail, and the CLIK23 repeats 
and the tail. It has previously been shown that the presence of the tail in hlCaP, 
h2CaP and h3CaP causes a reduction in the actin binding, and that the effects are 
more pronounced in h2CaP and h3CaP (Burgstaller et al., 2002; Danninger and 
Gimona, 2000). Notably, the isoelectric points (pis) of the CaP tails vary 
considerably. The pi of hlCaP C-terminal tail is 5.88, whereas h2CaP and h3CaP tails 
have pis of 3.09 and 3.53, respectively (Danninger and Gimona, 2000). These data
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suggest that a more acidic tail probably reduces the affinities of CaPs for actin 
filaments. Indeed, almost 80% of the cellular hlCaP was retained in the cytoskeletal 
fractions of NIH 3T3 cells, while only 25% and 40% of the cellular h2CaP and h3CaP 
were retained (Danninger and Gimona, 2000). Thus, the pi of the hlCaP tail could 
account for less stringent regulation on the CLIK23 repeats, and the electrostatic 
interactions between the tails and CLIK23 repeats of h2CaP and h3CaP could be 
significantly higher, with the consequence of an even increased reduction in their 
actin-binding affinities compared to hlCaP. The in-silico modelling approach used to 
model the CH domain -  tail interaction of hlCaP could also be applied to the other 
two isoforms but to date there are no homologous sequences in the data-bank of the 
National Center for Biotechnology Information (NCBI) that can be used as a template 
to provide a reliable three-dimensional structure for the tails of h2CaP and h3CaP. In 
addition, subtle differences are found at the amino-acid level between the CH domains 
of the CaPs, and the crystal structures of h2CaP and h3CaP CH domains have not yet 
been determined. These differences in the CH domains might account for an isoform 
specific mechanism of CH domain -  tail interaction. Indeed, Arg44, Arg45 and Asn49 
of hlCaP, which were predicted to be the major contributors to the stabilization of the 
CH domain and tail interaction, are not found in h2CaP, and only Asn49 is present in 
h3CaP. Therefore, it would be of great value to analyze the modes of interactions 
between the CH domains and the tails of these other two CaP isoforms.
Although CaPs might share similar regulatory mechanisms to modulate their 
actin-binding behaviour, they may well interact with different accessory proteins that 
control the interactions between their CH domains and C-terminal tails. It is known 
that hlCaP binds to TM, Ca2+/CaM and S100, whereas h3CaP does not (Fujii et al., 
2002; Mezgueldi et al., 1992; Vancompernolle et al., 1990; Wills et al., 1993). Thus,
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considering the differences in the amino-acid sequences of CaPs and the different 
binding partners, one cannot rule out the possibility that the actin-binding activities of 
h2CaP and h3CaP are regulated in a different ways.
5.5 CaPs are involved in cytokinesis
In this study I have shown that CaPs not only bind to actin filaments during 
interphase but also throughout cell division, and overexpression of hlCaP mutants 
leads to aberrant cell division. The defects observed during cytokinesis in hlCaPAT 
overexpressing cells may be due to a lack of control of hlCaP actin-binding 
dynamics, owing to the absence of the tail sequence. Indeed, FRAP experiments with 
transfected full-length hlCaP during ingression furrow formation show a faster 
fluorescence recovery compared to hlCaP during interphase suggesting the presence 
of a molecular mechanism that regulates the actin-binding kinetics. CaPs were found 
mainly in the ingression furrow and the contractile ring. These actin-based structures 
are contractile and many cytoskeletal proteins are associated with them, including 
actin-crosslinking proteins (e.g. cortexillin and a-actinin) and myosin II (Reichl et al., 
2008). The contractile property of the ingression furrow and the contractile ring is 
what allows the constriction of the plasma membrane. HlCaP inhibits the actin- 
activated ATPase activity of myosin in vitro (Abe et al., 1990), therefore, during 
cytokinesis it might control the cyclic ATPase activity of myosin II. Furthermore, 
calcium-binding proteins could play a key role in controlling the inhibitory activity of 
hlCaP on the actin-activated ATPase activity of myosin (see 5.3). Ca2+/CaM was 
shown to localize at the cleavage furrow (Li et al., 1999), and thus it could release 
hlCaP from actin filaments and alleviate the inhibitory activity of hlCaP that is 
exerted on myosin, while it activates MLCK (Pearson et al., 1988). CaM activation of
113
MLCK regulates the force-generating actomyosin ATPase activity that is necessary 
for the gliding of filaments during cytokinesis. Whether h2CaP and h3CaP might also 
regulate myosin II during cell division remains to be determined in detail. It is still 
largely unknown whether h2CaP can inhibit the ATPase activity of myosin and, 
h3CaP has little effect on the myosin activity (Fujii et al., 2002). This might be due to 
the presence of a short ABS (spanning residues V 142 to 1163) in hlCaP, which is 
non-functional in h2CaP, and was shown to be responsible for the inhibition of the 
ATPase activity of myosin II (Mezgueldi et al., 1995).
A role of calponins in cell division is consistent with previous results. It was 
shown before that overexpression of hlCaP in cultured smooth muscles cells and 
fibroblasts suppresses their proliferation (Jiang et al., 1997). Also, hlCaP-deficient 
mice display increased bone formation, although it cannot be excluded that this 
increment in cell number is due to a increment in the expression levels of the bone 
morphogenetic protein (BMP), which is a potent initiator of cartilage and bone 
formation (Yoshikawa et al., 1998). In addition, during smooth muscle injury, 
quiescent SMCs change their phenotype and become proliferative at the same time as 
hlCaP expression levels are reduced (Samaha et al., 1996). More recently, it was 
shown that TNF-a and PDGF-BB, which are potent inducers of cell proliferation, are 
able to reduce the expression levels of hlCaP (Sugenoya et al., 2002). All these data 
imply a role for hlCaP as a suppressor of cell proliferation and underscore the 
necessity for cells to control the expression/activation levels of hlCaP during cell 
division.
Although phosphorylation of hlCaP does not seem to play a key role in cells 
in interphase, it could be important during cytokinesis. In this study was shown that 
hlCaP-S175/254A mutation deregulate cell division while division progress normally
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with the hlCaP-S175/254D mutants. However, the cellular localization of these two 
mutants in dividing cells differs significantly compared to the wild-type hlCaP. 
During cell division, hlCaP localizes to the cell periphery and the contractile ring, 
whereas both serine mutants are found in the whole cell, possible due to the necessity 
of the hydroxyl groups of the serines for actin binding activity of hlCaP (see section 
5.1). The function of hlCaP during cytokinesis might be controlled by ROCK, that is 
able to phosphorylate hlCaP in vitro, and which localizes at the contractile ring and 
regulates cytokinesis (Kosako et al., 1999; Yasui et al., 1998); hence ROCK could 
also act on hlCaP to control its actin-binding activity and thus its influence on cell 
division. Interestingly, using a phospho-motif finder (Amanchy et al., 2007) I have 
detected several motifs in the hlCaP sequence that may be recognized by a variety of 
signalling molecules such as STAT3, FRIP, Crk, RasGAP, she and Grb, and it will be 
of interest to determine whether hlCaP interacts with these components in vitro and 
in vivo. Such efforts could lead to the identification of the signalling pathway(s) that 
regulate hlCaP function and activity.
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ABBREVIATIONS
ABD actin-binding domain
ABP actin-binding protein
ABS actin-binding site
Ac acidic region
ADF actin depolymerization factor
ADP adenosine diphosphate
APBS adaptive Poisson-Boltzman solver
ARE actin responsive element
ARHGEF Rho guanine nucleotide exchange factor
Arp actin related protein
Arpc actin related protein complex
ATP adenosine triphosphate
BMP bone morphogenic protein
CAD caldesmon
CaM calmodulin
CaMKII calmodulin kinase II
CaP calponin
CaPZ capping protein Z
Cdc42 cell division cycle 42
CFP cyan fluorescent protein
CH calponin-homology
CLIK23 calponin-like repeats
DH Dbl homology
DMEM Dulbecco’s Modified Eagles Medium
DNA deoxyribonucleic acid
Dp dystrophin protein
EDTA ethylenediamine tetraacetic acid
eMLC essential myosin light chain
F-actin filament actin
FLN filamin
FRAP fluorescence recovery after photobleaching
FRET fluorescence resonance energy transfer
G-actin globular actin
GAP GTPase-activating protein
GBD GTPase-binding domain
GDI guanine nucleotide dissociation inhibitors
GEF guanine exchange factor
GFP green fluorescent protein
GST glutathione-S-transferase
GTP guanosine triphosphate
GTPase guanosine triphosphatase
hlCaP basic calponin
h2CaP neutral calponin
h3CaP acidic calponin
HEPES 4-(2-hydroxy-ethyl)-piperazine-l-ethane-sulfonic acid
IL interleukin
IPTG isopropyl-P-D-l-thiogalactopyranoside
IUP intrinsically unstructured protein
-kDa kilo Dalton
LIMK LIM kinase
MAPK mitogen-activated protein kinase
MARCKS myristoylated alanine-rich C kinase substrate
mDia mammalian diaphanous
MHC myosin heavy chain
MLC myosin light chain
MLCK myosin light chain kinase
MTOC microtuble-organizing center
NCBI National Center for Biotechnology Information
NF neurofilament
N-WASp neuronal WASp
PBS phosphate buffered saline
PCR polymerase chain reaction
PDGF platelet-derived growth factor
PH pleckstrin-homology
PI phosphatidylinositol
pi isoelectric point
PIP phosphatidylinositol phosphate
PIP2 phosphatidylinositol (4,5)-bisphosphate
PIP3 phosphatidylinositol (3,4,5)-triphosphate
PKC protein kinase C
PMSF phenyl-methylsulphonyl fluoride
Rac Ras-related C3 botulinum toxin substrate
Rho Ras homology
rMLC regulatory myosin light chain
ROCK Rho kinase
SDS sodium dodecyl sulfate
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis
SH3 src homology domain 3
SM22 smooth muscle protein 22
SMC smooth muscle cell
SMCaBP smooth muscle calcium binding protein
TGF transforming growth factor
TGN transgelin
TM tropomyosin
Tmod tropomodulin
Tn troponin
TNF tumor necrosis factor
V CA verproline-cofilin-homology-acidic
WASp Wiskot-Aldrich-syndrome protein
WH WASp homology
YFP yellow fluorescent protein
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